<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006400" GROUP_ID="MUSKEL" ID="184506031318160846" MERGED_FROM="" MODIFIED="2008-11-13 19:14:25 +0100" MODIFIED_BY="Elizabeth Tanjong Ghogomu" REVIEW_NO="C018-R" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="2.2">
<COVER_SHEET MODIFIED="2008-11-13 12:33:39 -0500" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<TITLE MODIFIED="2008-05-13 02:56:16 -0400" MODIFIED_BY="[Empty name]">Dietary interventions for rheumatoid arthritis</TITLE>
<CONTACT>
<PERSON ID="12689" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kåre Birger</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hagen</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Researcher</POSITION>
<EMAIL_1>k.b.hagen@medisin.uio.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>National Resource Centre for Rehabilitation in Rheumatology</DEPARTMENT>
<ORGANISATION>Diakonhjemmet Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2>PO Box 23 Vindern</ADDRESS_2>
<CITY>0319 Oslo</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>+(47) 22454855</PHONE_1>
<PHONE_2>+47 22 45 48 50</PHONE_2>
<FAX_1>+ 47 24 16 32 75</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-13 12:33:39 -0500" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<PERSON ID="12689" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kåre Birger</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Hagen</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Researcher</POSITION>
<EMAIL_1>k.b.hagen@medisin.uio.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>National Resource Centre for Rehabilitation in Rheumatology</DEPARTMENT>
<ORGANISATION>Diakonhjemmet Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2>PO Box 23 Vindern</ADDRESS_2>
<CITY>0319 Oslo</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>+(47) 22454855</PHONE_1>
<PHONE_2>+47 22 45 48 50</PHONE_2>
<FAX_1>+ 47 24 16 32 75</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="F3FC9C2D82E26AA201D6C2759F4ECFAE" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Marte</FIRST_NAME>
<MIDDLE_INITIALS>Gjeitung</MIDDLE_INITIALS>
<LAST_NAME>Byfuglien</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical nutritionist</POSITION>
<EMAIL_1>Marte.byfuglien@diakonsyk.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Diakonhjemmet Hospital</ORGANISATION>
<ADDRESS_1>PO Box 23 Vindern</ADDRESS_1>
<ADDRESS_2/>
<CITY>Oslo</CITY>
<ZIP>0319</ZIP>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>+ 4722451648</PHONE_1>
<PHONE_2/>
<FAX_1>+4722454877</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17861" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Louise</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Falzon</LAST_NAME>
<SUFFIX/>
<POSITION>Trials Search Coordinator</POSITION>
<EMAIL_1>louise.falzon@mountsinai.org</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Integrative &amp; Behavioral Cardiology Program</DEPARTMENT>
<ORGANISATION>Mount Sinai School of Medicine</ORGANISATION>
<ADDRESS_1>One Gustave L. Levy Place</ADDRESS_1>
<ADDRESS_2>Box 1030</ADDRESS_2>
<CITY>New York</CITY>
<ZIP>10029-6574</ZIP>
<REGION>NY</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>(212) 241-4464</PHONE_1>
<PHONE_2/>
<FAX_1>(212)241-4000</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="F3FE46C182E26AA201D6C275D6CA4CE0" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Sissel</FIRST_NAME>
<MIDDLE_INITIALS>Urke</MIDDLE_INITIALS>
<LAST_NAME>Olsen</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical nutritionist</POSITION>
<EMAIL_1>Sisselurke.olsen@diakonsyk.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Diakonhjemmet Hospital</ORGANISATION>
<ADDRESS_1>PO box 23 Vindern</ADDRESS_1>
<ADDRESS_2/>
<CITY>Oslo</CITY>
<ZIP>0319</ZIP>
<REGION/>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>+ 4722451648</PHONE_1>
<PHONE_2/>
<FAX_1>+4722454877</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9284AA0182E26AA201AFF012B3991350" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Geir</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Smedslund</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>ges@nokc.no,Geir.Smedslund@kunnskapssenteret.no</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Norwegian Knowledge Centre for the Health Services</ORGANISATION>
<ADDRESS_1>Postboks 7004</ADDRESS_1>
<ADDRESS_2>St. Olavs plass</ADDRESS_2>
<CITY>Oslo</CITY>
<ZIP/>
<REGION>N-0130</REGION>
<COUNTRY CODE="NO">Norway</COUNTRY>
<PHONE_1>47 2325 5155</PHONE_1>
<PHONE_2>47 9138 7076</PHONE_2>
<FAX_1>47 2325 5010</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-11-11 10:26:33 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="15" MONTH="1" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="15" MONTH="1" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="13" MONTH="11" YEAR="2008"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2008-06-09 11:25:11 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-06-09 11:25:11 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
<P>CMSG ID: C018-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-11-11 10:26:56 -0500" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Diakonhjemmet Hospital</NAME>
<COUNTRY CODE="NO">Norway</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-13 12:39:46 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-11-13 12:39:46 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-11-13 12:37:38 -0500" MODIFIED_BY="[Empty name]">The effect of diets on rheumatoid arthritis</TITLE>
<SUMMARY_BODY MODIFIED="2008-11-13 12:39:46 -0500" MODIFIED_BY="[Empty name]">
<P>A review of the effect of diets for people with rheumatoid arthritis was conducted by researchers in the Cochrane Collaboration.  After searching for all relevant studies, they found 15 studies done by other researchers.  Their findings are summarised below. </P>
<P>
<B>What is rheumatoid arthritis and what diets have been tried?</B>
</P>
<P>Rheumatoid arthritis is a disease in which the body's immune system attacks the lining of the joints.  Usually, the joints of the hands and feet are affected first.  Joints will become swollen, stiff and painful.  There is no cure for RA at present, so treatments aim to relieve pain and stiffness, and improve the ability to move. </P>
<P>To improve symptoms, some people have tried to change what they eat by following a wide variety of special diets.  Some people will try to not eat anything for 7 to 10 days to see if it makes a difference.  But usually people will try to limit or increase only certain foods.  The most common diets tried are vegetarian or vegan, Mediterranean, 'elemental' , or elimination diets.   Vegan diets do not include meat, fish, eggs and milk products, while some vegetarian diets allow eggs and milk.  Mediterranean diets usually include a small amount of meat, more fish, more fruits and vegetables and olive oil.  Elemental diets are usually liquid diets that contain nutrients that are broken down to make digestion easier.  Elimination diets are used to find foods that might be the cause of symptoms.  People usually eliminate foods they think are causing symptoms, and then add in the foods one at a time and see which ones cause symptoms.     </P>
<P>
<B>What the research says</B>
</P>
<P>It is uncertain whether diets improve pain, stiffness and the ability to move better.</P>
<P>Instead, diets may be difficult to stick to, and people may lose weight on these diets even though they did not plan to.<BR/>
<BR/>
</P>
<P>- people who follow special diets may lose 3 kg (6 ½ pounds) more than people who do not follow special diets, even though they did not plan to.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-11-10 00:34:00 -0500" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2008-08-13 07:07:39 -0400" MODIFIED_BY="[Empty name]">
<P>The question of what potential benefits and harms are associated with certain dietary regimes used in rheumatoid arthritis is an important one for many patients and health care providers.<BR/>
</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-08-13 07:07:39 -0400" MODIFIED_BY="[Empty name]">
<P>To assess the effectiveness and safety of dietary interventions in the treatment of rheumatoid arthritis.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-08-15 11:12:01 -0400" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL)(<I>The Cochrane Library,</I> issue 1 2008), MEDLINE, EMBASE, AMED, CINAHL and reference lists of relevant articles (up to January 2008), and contacted authors of included articles.<BR/>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-08-13 07:07:39 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) where the effectiveness of dietary manipulation was evaluated. Dietary supplement studies (including fish oil supplements) were not included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two authors independently selected trials for inclusion, assessed the internal validity of included trials and extracted data. Investigators were contacted to obtain missing information.<BR/> </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-11-10 00:34:00 -0500" MODIFIED_BY="[Empty name]">
<P>Fourteen RCTs and one CCT, with a total of 837 patients, were included. Due to heterogeneity of interventions and outcomes, baseline imbalance and inadequate data reporting, no overall effects were calculated. A single trial with a moderate risk of bias found that fasting, followed by 13 months on a vegetarian diet, may reduce pain (mean difference (MD) on a 0 to 10 scale -1.89, 95% confidence interval (CI) -3.62 to -0.16), but not physical function or morning stiffness immediately after intervention. Another single trial with a moderate risk of bias found that a 12-week Cretan Mediterranean diet may reduce pain (MD on a 0 to 100 scale -14.00, 95% CI -23.6 to -4.37), but not physical function or morning stiffness immediately after intervention. Two trials compared a 4-week elemental diet with an ordinary diet and reported no significant differences in pain, function or stiffness. Due to inadequate data reporting, the effects of vegan and elimination diets are uncertain. When comparing any dietary manipulation with an ordinary diet we found a significantly higher total drop-out of 10% (risk difference (RD) 0.10, 95% CI 0.02 to 0.18), higher treatment-related drop-out of 5% (RD 0.05, 95% CI -0.03 to 0.14) and a significantly higher weight loss (weighted mean difference -3.23, 95% CI -4.79 to -1.67 kg) in the diet groups compared to the control groups.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-08-13 07:07:39 -0400" MODIFIED_BY="[Empty name]">
<P>The effects of dietary manipulation, including vegetarian, Mediterranean, elemental and elimination diets, on rheumatoid arthritis are still uncertain due to the included studies being small, single trials with moderate to high risk of bias. Higher drop-out rates and weight loss in the groups with dietary manipulation indicate that potential adverse effects should not be ignored.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-13 01:33:28 -0500" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-11-13 01:33:28 -0500" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2008-08-13 07:07:39 -0400" MODIFIED_BY="[Empty name]">
<P>Rheumatoid arthritis is a chronic autoimmune disease that affects between 0.3% and 1.0% of the general population and has a significant impact on patients' physical, emotional and social functioning (<LINK REF="REF-Uhlig-2005" TYPE="REFERENCE">Uhlig 2005</LINK>; <LINK REF="REF-Uhlig-2007" TYPE="REFERENCE">Uhlig 2007</LINK>). Although new drugs have shown promising effects, they are also associated with significant side effects. </P>
</CONDITION>
<INTERVENTION MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>For decades patients have used different diets to try to improve the symptoms of rheumatoid arthritis and dietary manipulation is still widely used today. Dietary changes may influence the body through several different mechanisms, such as decreasing the inflammatory process, increasing antioxidant levels, changing the lipid profile, and possibly altering the balance of intestinal bacterial flora. The common dietary regimes used by people with rheumatoid arthritis include vegetarian or vegan, Mediterranean, 'elemental' and 'elimination' diets. The vegetarian diet can be either strictly vegan, vegan with or without gluten, or lacto-ovo-vegetarian (including dairy products and eggs).</P>
</INTERVENTION>
<THEORY MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>Possible mechanisms of action for dietary manipulation to produce health benefits may include the consequent changes in intestinal flora, and the elimination of possible offending foods. Vegan type diets are also higher in antioxidants and this may be a causal factor in reduced pain and stiffness (<LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>). The Mediterranean diet and especially the Cretan diet are high in fruit, vegetables, cereals and legumes, low in red meat, and high in fish and olive oils. These diets could have a protective effect due to their high levels of unsaturated fat and antioxidants (<LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>).</P>
<P>The 'elimination' diet is another type of dietary regime whereby patients remove one or more potentially offending food items. These food items are then gradually reintroduced to find out whether any of them aggravate symptoms (<LINK REF="STD-Darlington-1986" TYPE="STUDY">Darlington 1986</LINK>). Elimination therapy is based on the belief that a food antigen plays a role in the pathogenesis of a disease and that its elimination from the diet should result in symptom improvement (<LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK>).</P>
<P>The 'elemental' diet is believed to be hypoallergenic, and comprises the simplest formulations of amino acids, glucose, medium-chain triglycerides, vitamins and minerals. It is industrially pre-made, is pre-packed in sachets and is used to replace one or more meals a day.</P>
</THEORY>
<IMPORTANCE MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>Previous reviews have reported promising effects of dietary manipulation in the management of rheumatoid arthritis, but emphasise the need for more and better research before any firm conclusions can be drawn (<LINK REF="REF-M_x00fc_ller-2001" TYPE="REFERENCE">Müller 2001</LINK>; <LINK REF="REF-Rennie-2003" TYPE="REFERENCE">Rennie 2003</LINK>). The possible risks or adverse effects of dietary manipulation have not been emphasised in these reviews. Since many people with rheumatoid arthritis may already be compromised nutritionally due to difficulty buying or preparing meals, they may be especially vulnerable to the adverse effects of additional diet restrictions. Therefore, the question of what benefits or harms may be associated with different dietary regimes in rheumatoid arthritis remains an important one for many patients and health care providers.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>To assess the effectiveness and safety of dietary interventions in the treatment of rheumatoid arthritis.</P>
<P>The following main comparisons were made.</P>
<OL>
<LI>Dietary manipulation versus usual diet.</LI>
<LI>Comparison of different dietary regimes.</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-11 12:08:20 -0500" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-08-05 13:24:41 -0400" MODIFIED_BY="Jenny Bellorini">
<CRIT_STUDIES MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>Studies were eligible if they were randomised controlled trials or cluster-randomised trials. Controlled clinical trials (CCTs) using inadequate generation of sequence (i.e. case record numbers, alternation, date of admission, date of birth etc.) when allocating patients to different groups were also eligible.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>Patients with rheumatoid arthritis, as defined by the American College of Rheumatology (ACR) (<LINK REF="REF-Arnett-1988" TYPE="REFERENCE">Arnett 1988</LINK>) or other acceptable criteria.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>Studies included at least one treatment group in which a dietary intervention was applied. We included any dietary manipulation, such as elimination diets, diets described as Mediterranean or Cretan, vegetarian, acid-base balance and fasting. Dietary supplement studies were not included (including fish oil supplements). The use of medication, alternative therapies or lifestyle changes was to be comparable in the groups studied. The comparison included other interventions (including other dietary interventions), placebo interventions or usual diet.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-05 13:24:41 -0400" MODIFIED_BY="Jenny Bellorini">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>The primary outcomes considered were pain, functional status, joint stiffness, fatigue and possible adverse effects (such as the number of withdrawals due to adverse events, unwanted weight loss, gastrointestinal symptoms and others).</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>Secondary outcomes included health-related quality of life, medication use and other outcomes important for patients. We only considered outcomes measured with validated instruments.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-15 11:10:37 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2008-08-15 11:10:37 -0400" MODIFIED_BY="[Empty name]">
<P>We identified relevant studies by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library,</I> issue 1 2008), MEDLINE, EMBASE, AMED and CINAHL (up to January 2008), without using any language restrictions.</P>
<P>The search strategy set out in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> was used in MEDLINE.<BR/>
</P>
<P>We adapted similar search strategies to search the other databases.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-08-13 07:07:40 -0400" MODIFIED_BY="[Empty name]">
<P>We also scanned the reference lists of included studies and relevant reviews to identify additional relevant trials. We contacted authors of included studies when the reported information was unclear and/or additional information was needed.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-11 12:08:20 -0500" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2008-08-15 11:14:10 -0400" MODIFIED_BY="[Empty name]">
<P>Two authors (SUO and MGB) independently screened the abstracts of all publications obtained from the searches. We retrieved all abstracts that at least one author considered relevant in full text. We resolved uncertainty or disagreement by discussion. When further information was needed, we contacted the authors of studies for clarification. We obtained and assessed all potentially eligible articles, based on the inclusion and exclusion criteria. Trials excluded after reading the full text reports are presented with reasons for exclusion in the table 'Characteristics of excluded studies'.</P>
</STUDY_SELECTION>
<QUALITY_ASSESSMENT MODIFIED="2008-11-11 11:18:55 -0500" MODIFIED_BY="[Empty name]">
<P>In order to ensure that variation in effects was not caused by systematic errors in the study design or execution, two authors independently assigned each selected study to quality categories (i.e. assessment of risk of bias). We resolved uncertainty or disagreement by discussion. When further information was needed, we contacted the authors of studies for clarification. We used the following seven criteria.</P>
<P>1) Random generation of allocation<BR/>MET: Resulting sequences are unpredictable (explicitly stated use of either computer-generated random numbers, table of random numbers, drawing lots or envelopes, coin tossing, shuffling cards, or throwing dice).<BR/>UNCLEAR: Vague statement that the study was randomised but not describing the generation of the allocation sequence.<BR/>NOT MET: Explicit description of inadequate generation of sequence (i.e. using case record numbers, alternation, date of admission, date of birth) or clear that allocation concealment was not used.</P>
<P>2) Concealment of allocation<BR/>MET: Indicates adequate concealment of the allocation (for example, by telephone randomisation or use of consecutively numbered, sealed, opaque envelopes).<BR/>UNCLEAR: Indicates uncertainty about whether the allocation was adequately concealed (for example, where the method of concealment is not known).<BR/>NOT MET: Indicates that the allocation was definitely not adequately concealed (for example, open random number lists or quasi-randomisation such as alternate days, odd/even date of birth, or hospital number) or explicit statement that the allocation was not random.<BR/>
</P>
<P>3) Outcome assessment<BR/>MET: Assessor unaware of the assigned treatment when collecting outcome measures.<BR/>UNCLEAR: Blinding of assessor not reported and cannot be verified by contacting investigators.<BR/>NOT MET: Assessor aware of the assigned treatment when collecting outcome measures.</P>
<P>4) Co-intervention<BR/>MET: Interventions other than diets avoided, controlled or used similarly across comparison groups.<BR/>UNCLEAR: Use of interventions other than diets not reported and cannot be verified by contacting the investigators.<BR/>NOT MET: Dissimilar use of interventions other than diets across comparison groups, i. e. differences in the care provided to the participants in the comparison groups other than the intervention under investigation.</P>
<P>5) Losses to follow-up<BR/>MET: Losses to follow-up less than 20% and equally distributed between comparison groups.<BR/>UNCLEAR: Losses to follow-up not reported.<BR/>NOT MET: Losses to follow-up greater than 20% in at least one of the groups.</P>
<P>6) Blinding of provider or patient<BR/>MET: The patient or the provider or both were blinded to the intervention.<BR/>UNCLEAR: Blinding not reported.<BR/>NOT MET: The patient and the provider were not blinded to the intervention.</P>
<P>7) Intention-to-treat<BR/>MET: Intention-to-treat analysis performed or possible with data provided.<BR/>UNCLEAR: Intention-to-treat not reported, and cannot be verified by contacting the investigators.<BR/>NOT MET: Intention-to-treat analysis not done and not possible for review authors to calculate independently.</P>
<P>We grouped studies as those with a low risk of bias or high internal validity (6 to 7 criteria MET), those with a moderate risk of bias (3 to 5 criteria MET), and those with a high risk of bias or low internal validity (less than 3 criteria MET). We also collected and documented other methodological issues such as baseline comparability, sample size etc.</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-11-11 12:08:20 -0500" MODIFIED_BY="[Empty name]">
<P>We made comparisons separately according to type of intervention and control group. Due to heterogeneity in the interventions and outcome measures and inadequate data reporting, we calculated no overall clinical effects. Although most articles of the included trials reported within-group differences between baseline and end of study, only between-group analyses are provided in the present review. Thus, for studies which reported data sufficiently for recalculation of between-group differences, we recalculated and presented results as mean differences (MD) or risk ratios (RR) with 95% confidence intervals (CI). For possible adverse effects (total drop-outs and treatment-related drop-outs) we calculated risk differences (RD) and 95% CI by pooling trials comparing any diet manipulation with ordinary diet.</P>
<SUBSECTION>
<HEADING LEVEL="4">Grading of evidence</HEADING>
<P>In addition, we used the grading system described and recommended by the Musculoskeletal Group (<LINK REF="REF-Tugwell-2004" TYPE="REFERENCE">Tugwell 2004</LINK>):</P>
<P>Platinum: a published systematic review that has at least two individual randomised controlled trials each satisfying following:</P>
<UL>
<LI>sample sizes of at least 50 per group - if these do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome;</LI>
<LI>blinding of patients and assessors for outcomes;</LI>
<LI>handling of withdrawals: &gt; 80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) are acceptable);</LI>
<LI>concealment of treatment allocation.</LI>
</UL>
<P>Gold: at least one randomised clinical trial meeting all of the following criteria for the major outcome(s) as reported:</P>
<UL>
<LI>sample sizes of at least 50 per group - if these do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome;</LI>
<LI>blinding of patients and assessors for outcomes;</LI>
<LI>handling of withdrawals &gt; 80% follow up (imputations based on methods such as LOCF are acceptable);</LI>
<LI>concealment of treatment allocation.</LI>
</UL>
<P>Silver: randomised trials that do not meet the above criteria. Silver ranking would also include evidence from at least one study of non-randomised cohorts that did and did not receive the therapy, or evidence from at least one high quality case-control study. A randomised trial with a 'head-to-head' comparison of agents would be considered silver-level ranking, unless a reference was provided for comparison of one of the agents to placebo, and showing at least a 20% relative difference.</P>
<P>Bronze: the bronze ranking is given to evidence if at least one high quality case series without controls (including simple before/after studies in which patients act as their own control) or if the conclusion is derived from expert opinion based on clinical experience, without reference to any of the foregoing (for example, argument from physiology, bench research or first principles).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Clinical relevance tables</HEADING>
<P>Clinical relevance tables are compiled under additional tables to improve the readability of the review. For dichotomous outcomes, we calculated the numbers needed to treat. Continuous outcome tables are also presented under additional tables. Absolute benefit is calculated as the improvement in the intervention group minus the improvement in the control group, in the original units. We calculated the relative difference in the change from baseline as the absolute benefit divided by the baseline mean of the control group.</P>
</SUBSECTION>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-11 12:27:05 -0500" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-11-11 12:06:10 -0500" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2008-08-13 07:07:42 -0400" MODIFIED_BY="[Empty name]">
<P>The electronic searches identified 1029 studies, of which 967 were clearly not relevant, and 62 were retrieved in full text. Forty-seven of these were excluded, thus 15 trials were included in this review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-11-11 12:06:10 -0500" MODIFIED_BY="[Empty name]">
<P>Fourteen RCTs, with a total of 707 participants and one CCT (<LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK>) with 130 participants, published between 1979 and 2007, were included in this review. One was undertaken in the USA, eight in the Nordic countries, four in the UK, one in Italy and one in the Netherlands.</P>
<SUBSECTION>
<HEADING LEVEL="4">Comparisons</HEADING>
<P>Two of the studies (<LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>; <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK>) compared 7 to 10 days of fasting followed by a vegetarian diet with an ordinary diet. Two studies (<A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A>; <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK>) compared an elemental diet with an ordinary diet, two studies compared an elemental diet with a well-mixed soup (<LINK REF="STD-Haugen-1994" TYPE="STUDY">Haugen 1994</LINK>) or oral prednisolone 15 mg/day (<LINK REF="STD-Podas-2007" TYPE="STUDY">Podas 2007</LINK>), while another study (<LINK REF="STD-van-de-Laar-1992" TYPE="STUDY">van de Laar 1992</LINK>) compared two different elemental diets. Another two studies (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK>; <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK>) compared vegan diets with an ordinary diet. Two studies (<LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK>; <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>) compared a Mediterranean diet with an ordinary diet or healthy eating, and one study (<LINK REF="STD-Darlington-1986" TYPE="STUDY">Darlington 1986</LINK>) compared an elimination diet with ordinary food. Finally, three studies (<LINK REF="STD-Hansen-1996" TYPE="STUDY">Hansen 1996</LINK>; <LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK>; <LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK>) compared different special diet regimens ('Dong-diet', 'Graastener-diet' and 'hypoallergenic-diet) with 'usual' or 'well-balanced' diets.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>Four studies included patients with rheumatoid arthritis diagnosed according to the 1987 ACR criteria (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK>; <A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A>; <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>; <LINK REF="STD-van-de-Laar-1992" TYPE="STUDY">van de Laar 1992</LINK>), while seven other studies included patients with rheumatoid arthritis diagnosed according to the ARA criteria (<LINK REF="STD-Hansen-1996" TYPE="STUDY">Hansen 1996</LINK>; <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK>; <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK>; <LINK REF="STD-Podas-2007" TYPE="STUDY">Podas 2007</LINK>; <LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK>; <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK>). Three studies included patients with 'definite' rheumatoid arthritis diagnosed according to other criteria (<LINK REF="STD-Darlington-1986" TYPE="STUDY">Darlington 1986</LINK>; <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>; <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK>; <LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK>). In eleven of the studies, between 70% and 100% of the participants were women. In one study (<LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK>) 34.6% of the participants were women, while one study did not provide information about the sex distribution (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK>). The participants' mean age varied between 49.5 years (<A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A>) and 58.5 years (<LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>). One study did not provide information regarding the participants' age (<LINK REF="STD-Darlington-1986" TYPE="STUDY">Darlington 1986</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>In most studies outcomes were measured by the end of the interventions, ranging from 4 weeks (<LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK>) to 13 months (<LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>), while in three studies outcomes were also measured at one to six months follow-up (<A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A>; <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK>; <LINK REF="STD-van-de-Laar-1992" TYPE="STUDY">van de Laar 1992</LINK>). Generally, many outcome measures were used. The median number of outcome measures was six (ranging from 1 to 10). One study (<LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>) explicitly defined four outcomes as primary outcome measures and two others (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK>; <LINK REF="STD-Podas-2007" TYPE="STUDY">Podas 2007</LINK>) defined one outcome measure (ACR-20 response criteria, i.e. a 20% improvement in tender and swollen joint counts plus a 20% improvement in three of the following five core measures: patient and physical global assessments, pain, functional status and an acute phase reactant). Pain and duration of morning stiffness was the most frequently used outcome measure (10 studies), number of tender and/or swollen joints in nine and physical functioning by Health Assessment Questionnaire (HAQ) in eight studies (outlined in detail in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table).</P>
<P>Ten trials reported on weight loss. One study (<LINK REF="STD-van-de-Laar-1992" TYPE="STUDY">van de Laar 1992</LINK>) did not report the reasons for drop-outs or any other adverse effects.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-11 11:34:24 -0500" MODIFIED_BY="[Empty name]">
<P>Three of the authors (MGB or KBH and GS) independently assessed 15 studies using seven criteria for validity, resulting in 105 separate assessments. There was initially agreement in 77 (73%) of the assessments, and disagreement between the authors in 28 (27%). The disagreements were easily resolved by discussion.</P>
<P>Twelve studies met three, four or five criteria of internal validity, and were assessed to have a moderate risk of bias. Three studies were assessed to have a high risk of bias. <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> and <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> met two criteria of internal validity and one study was a CCT (<LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK>). Four of the studies were described as 'double-blind' (<LINK REF="STD-Haugen-1994" TYPE="STUDY">Haugen 1994</LINK>; <LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK>; <LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK>; <LINK REF="STD-van-de-Laar-1992" TYPE="STUDY">van de Laar 1992</LINK>), i.e. both providers and patients were blinded, while in one study only patients were blinded (<LINK REF="STD-Darlington-1986" TYPE="STUDY">Darlington 1986</LINK>).</P>
<P>The studies by <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>, <LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK> and <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> were initially assessed as 'unclear' for 'random generation of allocation' and 'concealment of allocation', but were later graded as 'met' following correspondence with the authors. The study by <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> was initially assessed as 'unclear' for 'outcome assessment', but was later graded as 'not met' following correspondence with the contact author.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-11 12:27:05 -0500" MODIFIED_BY="[Empty name]">
<P>Most articles of the included trials reported within-group differences between baseline and end of study. Since the purpose of a RCT is to compare outcomes between groups, we only present between-group analyses in the present review.</P>
<SUBSECTION>
<HEADING LEVEL="3">Main comparison (1) - Dietary manipulations versus usual diet</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1.1 Seven to ten days with fasting followed by vegetarian diet compared with ordinary diet</HEADING>
<P>Two trials with a total of 79 patients were included in this comparison. <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK> (moderate risk of bias) compared 7 to 10 days of fasting followed by 3.5 months of a vegan diet and nine months with a lacto-vegetarian diet with usual diet. <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> (high risk of bias) compared 7 to 10 days of fasting followed by nine weeks on a lacto-vegetarian diet with usual diet.</P>
<SUBSECTION>
<HEADING LEVEL="5">Pain</HEADING>
<P>In the study of <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>, the mean difference (MD) in favour of the intervention group at three weeks follow-up was -1.06 (95% confidence interval (CI) -2.32 to 0.20; P = 0.10) and -1.89 (95% CI -3.62 to -0.16; P = 0.03) at 13 months follow-up. <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> found a mean difference in favour of the intervention group in change from baseline to nine weeks follow-up at -0.9 (95% CI -2.98 to 1.18; P = 0.40). In both studies pain was assessed on a 0 to 10 visual analogue scale (VAS).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Physical function</HEADING>
<P>The mean difference in Health Assessment Questionnaire (HAQ) score (0 to 3) in favour of the intervention group was -0.07 (95% CI -0.46 to 0.32; P = 0.72) at three weeks follow-up, and -0.07 (95% CI -0.48 to 0.34; P = 0.74) at 13 months follow-up in the study of <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>. <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> did not report on physical function.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stiffness</HEADING>
<P>In the study of <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK> the mean difference in morning stiffness (hours) in favour of the intervention group was -0.85 (95% CI -1.71 to 0.01; P = 0.05) at three weeks follow-up and -1.08 (95% CI -2.23 to 0.07; P = 0.07) at 13 months follow-up. <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> found a mean difference (on a 0 to 10 scale) in favour of the intervention group in change from baseline to nine weeks follow-up at -0.70 (95% CI -3.09 to 1.69; P = 0.57).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Body weight</HEADING>
<P>In the study of <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK> there was an imbalance between the groups at baseline (intervention group mean body weight 70.0 kg versus control group mean 66.9 kg). After 13 months, the intervention group had lost 4.6 kg, while the control group remained stable. Thus, although the intervention group had a significantly higher weight loss than the control group, there was no significant difference between the groups after 13 months (MD 1.5 kg, 95% CI -8.80 to 5.80; P = 0.69). In the study of <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> there was also a small difference between the groups at baseline (intervention group mean body weight 71.0 kg versus control group mean 68.5 kg). After nine weeks the intervention group had lost more weight than the control group; mean difference in change from baseline to nine weeks follow-up was -3.20 (95% CI -4.83 to -1.57; P &lt; 0.001).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>
<LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK> reported that the total number of drop-outs was 10 (37%) in the intervention group and nine (35%) in the control group, while the number of treatment-related drop-outs was five (18.5%) patients in the intervention group and seven (27%) in the control group. <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> reported that one (6%) patient withdrew in the diet group due to side effects and another experienced temporary side effects. See also <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.2 Vegan diet compared with ordinary diet</HEADING>
<P>Two trials (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> (moderate risk of bias); <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK> (moderate risk of bias)) with a total of 109 patients, compared 12 months with a vegan diet free of gluten (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK>) and three months with an uncooked vegan diet (<LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK>) with an ordinary diet.</P>
<SUBSECTION>
<HEADING LEVEL="5">Pain</HEADING>
<P>
<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> did not report on pain separately, while <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK> reported that the VAS for pain at rest and on movement did not behave statistically differently in the intervention and control groups (data not reported).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Physical function</HEADING>
<P>
<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> did not report on function separately, while <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK> reported that the HAQ score did not behave statistically differently in the intervention and control groups (data not reported).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stiffness</HEADING>
<P>
<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> did not report on stiffness separately, while <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK> reported that morning stiffness did not behave statistically differently in the intervention and control groups (data not reported).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Body weight</HEADING>
<P>
<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> did not report on body weight, while <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK> reported that "the intervention group lost weight, 9%, during the intervention, while the controls gained 1% of weight". The difference between the groups was significant (P = 0.0001).</P>
<P>Thus, none of the studies provided data on pain, physical function, stiffness or body weight separately for meta-analysis. <LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> , however, measured improvement in signs and symptoms with the ACR 20 response criteria (i.e. a 20% improvement in tender and swollen joint counts plus a 20% improvement in three of the five following remaining core measures: patient and physical global assessments, pain, functional status, and an acute phase reactant) and found that the response rate was higher in the vegan group than in non-vegan group after three months (RR 5.89, 95% CI 0.78 to 44.47), after six months (RR 4.79, 95% CI 1.17 to 19.55) and after 12 months (end of intervention) (RR 8.91, 95% CI 1.24 to 64.30).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>In the study by <LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK> three (7.9%) patients in the intervention group and two (7.2%) in the control group dropped out. Furthermore, they reported that 22 (57.9%) of the patients in the vegan group and 25 (89.3%) in the non-vegan group completed at least nine months of their diet, but reasons for non-compliance are not reported. <LINK REF="STD-Nenonen-1998" TYPE="STUDY">Nenonen 1998</LINK> reported that half of the patients experienced adverse effects (nausea, diarrhoea) during the diet and stopped the experiment prematurely; three during the first days and eight after two months. See also <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.3 Four weeks with elemental diet compared with ordinary diet</HEADING>
<P>Two trials (<A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A> (moderate risk of bias); <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> (high risk of bias)) with a total of 77 patients, compared four weeks with an elemental diet with an ordinary diet.</P>
<SUBSECTION>
<HEADING LEVEL="5">Pain</HEADING>
<P>In the study of <A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A> pain was measured on a 0 to 10 Numerical Rating Scale. At four weeks follow-up the median total pain score (defined as the sum of the following three pain scores: pain now, the worst pain during last week, the average pain level during the last week) was 12.0 in the intervention group and 16.0 in the control group (no significant difference). Neither at three nor six months follow-up were there any significant differences between the groups. <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> did not measure pain.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Physical function</HEADING>
<P>No significant difference in HAQ score was found in the study of <A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A> at four weeks follow-up (median score in the intervention group 0.88 compared to 1.32 in the control group), or at three and six months follow-up. In the study of <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> the mean functional score (type of scale not reported) was 9.7 and 10.5 in the intervention group and control group, respectively (no significant difference).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stiffness</HEADING>
<P>
<A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A> found no significant difference in the duration of morning stiffness at four weeks (median duration in the intervention group was 30 minutes compared to 75 minutes in the control group), or at three and six months follow up. <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> did not measure stiffness.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Body weight</HEADING>
<P>At four weeks follow up <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> reported that the intervention group had lost more weight than the control group; mean difference -3.9 kg (95% CI -11.12 to 3.32; P = 0.29). <A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A> reported that body mass index was the variable with the most pronounced change and that there was significant between-group differences after four weeks.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>
<A HREF="Holst-Jensen  1998">Holst-Jensen 1998</A> reported that two (13%) patients dropped out in the intervention group because of side effects, compared to none in the control group. Furthermore, they reported that "side effects were reported frequently and early in the course by ten of the thirteen (77%) patients that completed the intervention". In the trial of <LINK REF="STD-Kavanagh-1995" TYPE="STUDY">Kavanagh 1995</LINK> none of the patients in the intervention group dropped out during the four-week period of elemental diet compared to two (8.7%) in the control group. In total 11 (45.8%) patients in the intervention group and 18 (78.3%) patients in the control group dropped out of the study, but the reasons for the drop-outs are not described. See also <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.4 Mediterranean diet compared with ordinary diet/healthy eating</HEADING>
<P>We included one RCT (<LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> (moderate risk of bias)) with a total of 56 patients and one CCT (<LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> (high risk of bias)) with a total of 130 patients. <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> compared a 12-week Cretan Mediterranean diet with an ordinary diet, while <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> compared a six-week hands-on cooking course, backed up with written information, with written information only.</P>
<SUBSECTION>
<HEADING LEVEL="5">Pain</HEADING>
<P>After 12 weeks <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> found a significant difference (P = 0.004) in pain VAS (0 to 100 mm) in favour of the intervention group; mean difference -14.00 (95% CI -23.63 to -4.37). <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> reported significant differences in favour of the intervention group in VAS pain scores (0 to 100) at three and six months follow up (P = 0.011 and 0.049, respectively). In the intervention group the median score was 50, both at baseline, three months and six months follow up. In the control group the median scores were 55 at baseline, 62 at three months and 63 at six months follow up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Physical function</HEADING>
<P>After 12 weeks <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> reported a non-significant difference (P = 0.16) in HAQ score (0 to 3) in favour of the intervention group (MD -0.20, 95% CI -0.48 to 0.08). However, a significant difference (P = 0.012) in change from baseline to follow up in favour of the intervention group was reported. <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> reported a significant difference in favour of the intervention group in HAQ score (0 to 3) at three months follow up (P = 0.03). In the intervention group the median score was 1.75 at baseline and 1.625 at three and six months follow up. In the control group the median score was 1.75 at baseline and 1.87 at three and six months follow up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Stiffness</HEADING>
<P>
<LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> reported a non-significant difference (P = 0.11) in morning stiffness in favour of the intervention group; mean difference 26 minutes (95% CI -58.08 to 6.08). However, there were imbalances between the groups at baseline (intervention group mean 49 minutes versus control group mean 64). <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> reported a significant difference in favour of the intervention group in early morning stiffness at six months follow-up (P = 0.041). In the intervention group the median morning stiffness was 30 minutes at baseline and three months and 15 minutes at six months follow-up. In the control group the median morning stiffness was 60 minutes at baseline and 30 minutes at three and six months follow-up. Thus, there was considerable imbalance between the groups at baseline.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Body weight</HEADING>
<P>In the study of <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> there was imbalance between the groups at baseline (intervention group mean 78.9 kg versus control group mean 73.0 kg). After 12 weeks the average body weight was still higher in the intervention group (mean 75.9 kg) than in the control group (mean 72.6 kg). However, the change from baseline was significantly higher in the intervention group than the control group (P &lt; 0.001). <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> reported that the intervention group lost weight (median 0.9 kg over the six-month period), whereas the control group showed a weight gain (median 3 kg). This difference was not statistically significant.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>Five patients were excluded from <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>. Two in the control group because of inactive disease at the baseline assessment and three in the intervention group because of lack of motivation, relapse of a rheumatoid pleuritis and dyspepsia. Thus, two (6.9%) of the 29 patients allocated to the diet group withdrew because of the treatment compared to none in the control group. <LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK> did not report of any exclusions. See also <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.5 Elimination diet compared with ordinary diet</HEADING>
<P>One trial (<LINK REF="STD-Darlington-1986" TYPE="STUDY">Darlington 1986</LINK> (moderate risk of bias)) with a total of 53 patients, compared six weeks of elimination diet with ordinary diet. Due to inadequate data reporting, no between-group analyses were possible. The authors concluded as follows: "When the dietary and placebo groups were compared the dietary group did better for all thirteen variables for which differences between them was significant".</P>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>In total eight patients defaulted too early for analysis, but group allocation and reasons for the drop-outs are not described. Other possible adverse effects were not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.6 Special diet regimens compared with 'usual' or 'well-balanced' diets</HEADING>
<P>Three trials (<LINK REF="STD-Hansen-1996" TYPE="STUDY">Hansen 1996</LINK> (moderate risk of bias); <LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK> (moderate risk of bias); <LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK> (moderate risk of bias)), with a total of 192 patients, were included in this comparison.</P>
<P>
<LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK> (moderate risk of bias) compared 10 weeks of a diet free of additives, preservatives, fruit, red meat, herbs and dairy products ('Dong diet') with a placebo diet. Pain and body weight were not reported, whereas there were no significant differences in walking speed (function) and morning stiffness (data not reported).</P>
<P>
<LINK REF="STD-Hansen-1996" TYPE="STUDY">Hansen 1996</LINK> (moderate risk of bias) compared six months with a diet adjusted for energy intake, fish-meal and antioxidants ('Graastener diet') with ordinary diet. After six months there were no significant differences in change in VAS pain (MD -0.40, 95% CI -0.89 to 0.09; P = 0.11), HAQ score (MD -0.01, 95% CI -0.23 to 0.21; P = 0.93) or duration of morning stiffness (MD -3.00 minutes, 95% CI -23.47 to 17.47; P = 0.77) between the groups. Body weight was not reported.</P>
<P>
<LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK> (moderate risk of bias) compared 20 weeks of a hypoallergenic diet high in unsaturated fat and low in saturated fats with a well balanced diet. After six months on the diet there were no significant differences in VAS (0 to 100) pain (MD -2.80, 95% CI -13.33 to 7.73; P = 0.60), duration of morning stiffness (MD -5.20 minutes, 95% CI -27.59 to 17.19; P = 0.65) or body weight (MD 1.40, 95% CI -6.94 to 9.74; P = 0.74) between the groups. Physical function was not reported. See also <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>
<LINK REF="STD-Panush-1983" TYPE="STUDY">Panush 1983</LINK> reported that in total seven patients (21%) withdrew due to lack of interest or inability to comply, but group allocation and specific reasons for the drop-outs are not described. In the trial of <LINK REF="STD-Hansen-1996" TYPE="STUDY">Hansen 1996</LINK> 28 patients (25.7%) dropped out of the study, 18 (33.3%) of them were allocated to the diet group and 10 (18.2%) to the control group. Eighteen of the drop-outs were related to the treatment, but the group allocation was not reported. <LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK> reported that four patients (16%) in the control group and three patients (12%) in the intervention group dropped out, of which two (8%) in both groups were treatment-related.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Possible adverse effects when comparing any diet manipulation with ordinary diet</HEADING>
<P>By pooling six of the ten studies comparing any diet manipulation with an ordinary diet we found a significantly higher total drop-out rate in the diet group (risk difference (RD) 0.10, 95% CI 0.02 to 0.18 and relative risk (RR) 1.51, 95% CI 1.08 to 2.12). Five of the studies provided data on treatment-related drop-outs and the pooled risk difference was higher in the diet group, although not statistically significant (RD 0.05, 95% CI -0.03 to 0.14 and RR 1.56, 95% CI -0.72 to 3.37). Finally, eight of ten studies reported a significantly higher weight loss in the diet group compared with the ordinary diet group. Two studies (<LINK REF="STD-Hafstr_x00f6_m-2001" TYPE="STUDY">Hafström 2001</LINK>; <LINK REF="STD-Hansen-1996" TYPE="STUDY">Hansen 1996</LINK> ) did not report on weight loss. Five studies provided data on body weight. However, in four of them the intervention group was heavier than the control group at baseline (<LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK>; <LINK REF="STD-Sarzi_x002d_Puttini-2000" TYPE="STUDY">Sarzi-Puttini 2000</LINK>, <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK>; <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK>). Thus, by comparing changes from baseline to after intervention we found that the mean weight loss was 3.23 kg (95% CI 4.79 to 1.67) higher in the diet groups than in the control groups.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Main comparison (2) - comparison of different dietary manipulations</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">2.1 Four weeks with allergen-free diet versus allergen-restricted diet</HEADING>
<P>One trial <LINK REF="STD-van-de-Laar-1992" TYPE="STUDY">van de Laar 1992</LINK> (moderate risk of bias) with a total of 94 patients compared an allergen-free diet with an allergen-restricted diet containing only lactoproteins yellow dyes. After four weeks, no difference between the groups was found in morning stiffness, whereas the allergen-restricted group lost more weight (MD 1.10 kg, 95% CI 0.31 to 1.89; P = 0.006) than the allergen-free group. Pain and physical function were not reported.</P>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>In total 16 patients (17%) dropped out during the diet period, reported to be equally distributed between the two groups. However, the reasons for drop-outs or any other adverse effects were not reported.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.2 Three weeks with elemental diet versus a well-mixed blended soup</HEADING>
<P>One trial <LINK REF="STD-Haugen-1994" TYPE="STUDY">Haugen 1994</LINK> (moderate risk of bias) with 17 patients was included. After three weeks on diet the authors reported no significant differences in pain, morning stiffness or body weight (data not provided). Physical function was not measured.</P>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>Six of the patients (60%) in the elemental diet group reported diarrhoea compared to none in the control group.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.3 Two weeks with elemental diet versus oral prednisolone 15 mg/day</HEADING>
<P>One trial <LINK REF="STD-Podas-2007" TYPE="STUDY">Podas 2007</LINK> (moderate risk of bias) with 30 patients was included. After two weeks no significant differences in pain, physical function, stiffness or body weight were reported between the groups. Median VAS pain values were 4.9 in the elemental group and 2.6 in the prednisolone group and median HAQ scores were 1.8 in the elemental group and 1.4 in the prednisolone group. Median duration of morning stiffness was 105 minutes in the elemental group and nine minutes in the prednisolone group, while median body weight was 64.2 kg in the elemental group and 73.9 kg in the prednisolone group.</P>
<SUBSECTION>
<HEADING LEVEL="5">Possible adverse effects</HEADING>
<P>Three patients in the elemental diet group withdrew from the study; two found the elemental diet unpalatable and one had a deterioration of symptoms. In addition one patient receiving the elemental diet complained of constipation. No steroid treated patient withdrew during the study period.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-11 12:31:38 -0500" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2008-08-13 07:08:05 -0400" MODIFIED_BY="[Empty name]">
<P>In this review we found 11 randomised controlled trials and one controlled clinical trial, with a total of 696 patients, which compared dietary manipulation with an ordinary diet. In addition, we identified three RCTs, with a total of 141 patients, which compared different types of dietary manipulation. Results from single trials with moderate risk of bias indicate that both fasting followed by a vegetarian diet and a Cretan Mediterranean diet may improve pain when compared to an ordinary diet. However, no effects were found for physical function, stiffness or other important outcomes. Two trials with a moderate risk of bias indicate no effect of elemental diet. The effects of vegan and elimination diets are uncertain. Higher drop-out rates and weight loss in the groups with manipulated diets indicate that potential adverse effects should not be ignored.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2008-11-11 12:31:38 -0500" MODIFIED_BY="[Empty name]">
<P>Although some studies reported an improvement in some rheumatic symptoms, possible mechanisms of action are still unknown. Common denominators for most dietary interventions are an increase in fruits and vegetables and fibre, a reduction in saturated fat, calorie restriction and factors such as altered antioxidant levels, weight loss and allergies/intolerances, and have been proposed as possible mechanisms. It is therefore possible that simply changing from an unhealthy to a healthier diet during the study period could explain some of the positive changes in rheumatic symptoms. Also, when a dietary intervention is compared to ordinary eating, one cannot exclude the possibility that the beneficial effects in subjective outcomes can be attributed to a placebo effect.</P>
<P>Dietary manipulation is not for everybody, especially those at nutritional risk. The palatability and rigid regimens of some of these diets might reduce dietary intake. A more serious consequence of diet manipulation is the elimination of one or more food groups, which may lead to a potential risk of deficiency in several nutrients. For example, a strict vegan diet, without special diet planning, may cause deficiency in several vitamins and minerals, and protein. Not only does a strict dietary regime affect nutrition, but it is also difficult to maintain a social life when a special diet must be adjusted for. The safety of these diets is questionable and they are not recommended without consulting a clinical dietician. On the other hand, diets such as the Mediterranean regime include foods that most of us will aim to eat on a daily basis, such as moderate amounts of lean meat, unsaturated fats instead of saturated fats, plenty of fruits and vegetables, and fish daily. The diet is also nutritionally adequate and covers all the food groups. It is also recommended for people with heart disease and osteoporosis, and we know that people with rheumatoid arthritis are more prone to develop both (<LINK REF="REF-Solomon-2006" TYPE="REFERENCE">Solomon 2006</LINK>; <LINK REF="REF-van-Staa--2006" TYPE="REFERENCE">van Staa 2006</LINK>).</P>
<P>Despite the fact that rheumatoid arthritis patients may be especially vulnerable to the adverse effects of diet restrictions, the possible risks are not particularly emphasised in the included trials. By comparing any manipulated diet with ordinary diet we found a 10% higher total drop-out rate and 5% higher treatment-related drop-outs in the diet groups (although this was not statistically significant). Seven of the ten studies included in this comparison also reported a significantly higher weight loss in the diet group and the pooled estimate from five of these studies showed a 3.2 kg higher weight loss. There is empirical evidence indicating that low body mass, loss of fat-free body mass and abnormal vitamin B6 status are associated with the severity of symptoms in rheumatoid arthritis (<LINK REF="REF-Arshad-2007" TYPE="REFERENCE">Arshad 2007</LINK>; <LINK REF="REF-Chiang-2003" TYPE="REFERENCE">Chiang 2003</LINK>; <LINK REF="REF-Munro-1997" TYPE="REFERENCE">Munro 1997</LINK>) and that some of these effects do not seem to be reversable, even with adequate treatment (<LINK REF="REF-Metsios-2007" TYPE="REFERENCE">Metsios 2007</LINK>). There is even data indicating that a low body mass index is associated with a significantly increased risk of cardiovascular death (<LINK REF="REF-Kremers-2004" TYPE="REFERENCE">Kremers 2004</LINK>). Thus, the potential harmful effects of weight loss and a low body mass index in rheumatoid arthritis patients should definitely not be ignored.</P>
</APPLICABILITY_OF_FINDINGS>
<POTENTIAL_BIASES MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>There are several limitations of the present review. The results are based on relatively small and most often single trials, which we assessed to have moderate or high risk of bias. Most of the trials employed many different outcome measures, increasing the probability of detecting significant differences in some of them by chance. On the other hand, because we have only focused on pain, physical function, stiffness and side effects (i.e. the predefined primary outcomes) there might be effects on important outcomes that are not reported in the present review. Small trials may also be underpowered and thus increase the chance of not detecting clinically relevant differences. For example, in the study of <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK> the difference in morning stiffness was approximately one hour (P = 0.07) and in the study of <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> the difference in morning stiffness was 26 minutes (P = 0.11). These results may indicate that clinically relevant diffferences were not statistically significant because of lack of statistical power. However, in the study of <LINK REF="STD-Sk_x00f6_ldstam-2003" TYPE="STUDY">Sköldstam 2003</LINK> there were imbalances between the groups at baseline (intervention group mean 49 minutes versus control group mean 64), which illustrates the pitfalls associated with the analysis and interpretation of results from small trials. Also, the finding that in four of five studies that provided adequate data on body weight there were baseline differences in the same direction, underlines this problem. Two other studies also compared an ordinary diet with fasting followed by a vegetarian diet (<LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK>) and a Mediterranean diet (<LINK REF="STD-McKellar-2007" TYPE="STUDY">McKellar 2007</LINK>), respectively. Since the validity of these trials was low, the results were given low weight. The studies of <LINK REF="STD-Kjeldsen_x002d_Kragh-1991" TYPE="STUDY">Kjeldsen-Kragh 1991</LINK> and <LINK REF="STD-Sk_x00f6_ldstam-1979" TYPE="STUDY">Sköldstam 1979</LINK> also presented results for the fasting period separately. We have chosen not to emphasise these results because we considered fasting only as one element of the 'fasting-vegetarian' intervention and because fasting alone is not helpful unless there are lasting effects after patients start eating again.</P>
<P>Although all articles were randomised controlled trials or controlled clinical trials, many of them presented within-group analyses (baseline to end of study within groups) as the primary analysis. Since the purpose of a randomised controlled trial is to compare outcomes between groups, we only present between-group analyses in this review. Many studies therefore reported significant differences (within groups) which are not in concordance with the results presented in this review. Finally, the use of different outcome measures together with inadequate data reporting made quantitative data pooling, and thus a precise estimate of effects, impossible.</P>
<P>Since there is no 'gold standard' for assessing the internal validity of a trial, our approach can be discussed. For example, we considered blinding of providers and patients as recommended by the Cochrane Musculoskeletal Group, even where it was unlikely to be applicable when a strict diet regimen is compared to usual diet. However, even if blinding is not feasible, its absence may still be associated with bias. The beneficial effects of dietary manipulation, when compared to usual diet, may therefore in part be attributed to the placebo effect. Also, some empirical evidence suggests that review authors blinded to the names of authors, institutions and journals produce lower and more consistent scores than those who use open assessments (<LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK>), while other evidence does not show any effect of blinding on the results (<LINK REF="REF-Verhagen-1998" TYPE="REFERENCE">Verhagen 1998</LINK>). Because the number of trials in this review was relatively small, and we were familiar with most of the studies, we did not consider blinding.</P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-05 15:23:00 -0400" MODIFIED_BY="Jenny Bellorini">
<IMPLICATIONS_PRACTICE MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>The effects of dietary manipulation, including vegetarian, Mediterranean, elemental and elimination diets, are still uncertain due to the included studies in this review being small single trials with moderate to high risk of bias. There is some evidence that fasting followed by a vegetarian diet and a Cretan Mediterranean diet improve pain, but not stiffness and physical function, when compared to an ordinary diet. There is also some evidence that an elemental diet is not more effective than an ordinary diet. Few studies provided any long-term results or information on whether the experimental diet was used after the intervention period.  Of concern is the finding that dietary manipulation may be associated with higher drop-out rates, which may suggest difficulty following the diet.  Dietary manipulation may also be associated with weight loss, which can put patients at nutritional risk.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>Given the fact that dietary manipulation is still widely used, there is a need for more and better research on dietary interventions for rheumatoid arthritis. New trials should be sufficiently powered, use a limited number of predefined outcome measures and provide long-term follow-up measurements. Possible adverse effects should be emphasised.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>We want to thank the two anonymous referees and the editorial team at the Cochrane Musculoskeletal Group for constructive and relevant comments to the early versions of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>KBH planned and initiated the review, searched for RCTs, assessed the trials, extracted data, contacted authors of RCTs, drafted and redrafted the final review. MGB planned and initiated the review, searched for RCTs, assessed trials and contacted authors of RCTs. LF searched for RCTs and assessed trials. GS planned and initiated the review, assessed the trials and contributed to the statistical analyses. SUO planned and initiated the review, assessed the trials and extracted data. KBH is the guarantor for the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-11 11:27:35 -0500" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-08-15 11:01:45 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-08-13 07:41:17 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Darlington-1986" MODIFIED="2008-08-13 07:12:42 -0400" MODIFIED_BY="[Empty name]" NAME="Darlington 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-08-13 07:12:42 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Darlington LG, Ramsey NW, Mansfield JR</AU>
<TI>Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis</TI>
<SO>Lancet</SO>
<YR>1986</YR>
<VL>February</VL>
<PG>236-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Hafstr_x00f6_m-2001" MODIFIED="2008-08-13 07:13:46 -0400" MODIFIED_BY="[Empty name]" NAME="Hafström 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-08-13 07:12:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hafström I, Ringertz B, Spångberg A, Zweigbergk L, Brannemark S, Nylander I, et al</AU>
<TI>A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens</TI>
<SO>Rheumatology</SO>
<YR>2001</YR>
<VL>40</VL>
<PG>1175-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Hansen-1996" MODIFIED="2008-08-13 07:14:23 -0400" MODIFIED_BY="[Empty name]" NAME="Hansen 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-08-13 07:12:21 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hansen GVO, Nielsen L, Kluger E, Thysen M, Emmertsen H, Stengard-Pedersen K, et al</AU>
<TI>Nutrional status of Danish rheumatoid arthiritis patients and effects of a diet adjusted in energy intake, fish meal and antioxidants</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1996</YR>
<VL>25</VL>
<PG>325-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haugen-1994" MODIFIED="2008-08-13 07:14:44 -0400" MODIFIED_BY="[Empty name]" NAME="Haugen 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-08-13 07:14:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haugen MA, Kjeldsen-Kragh J, Førre Ø</AU>
<TI>A pilot study of the effect of an elemental diet in the management of rheumatoid arthritis</TI>
<SO>Clinical and Experimental Rheumatology</SO>
<YR>1994</YR>
<VL>12</VL>
<PG>275-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holst_x002d_Jensen--1998" MODIFIED="2008-08-13 07:22:06 -0400" MODIFIED_BY="[Empty name]" NAME="Holst-Jensen  1998" YEAR="1998">
<REFERENCE MODIFIED="2008-08-13 07:22:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holst-Jensen SE, Pfeiffer-Jensen M, Monsrud M, Tarp U, Buus A, Hessov I, et al</AU>
<TI>Treatment of rheumatoid arthritis with a peptide diet. A randomized, controlled trial</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1998</YR>
<VL>27</VL>
<PG>329-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kavanagh-1995" NAME="Kavanagh 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kavanagh R, Workman E, Nash P, Smith M, Hazleman BL, Hunter JO</AU>
<TI>The effects of elemental diet and subsequent food reintroduction on rheumatoid arthritis</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1995</YR>
<VL>34</VL>
<PG>270-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kjeldsen_x002d_Kragh-1991" MODIFIED="2008-08-13 07:22:45 -0400" MODIFIED_BY="[Empty name]" NAME="Kjeldsen-Kragh 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-08-13 07:22:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kjeldsen-Kragh J</AU>
<TI>Rheumatoid arthritis treated with vegetarian diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>70 (Suppl)</VL>
<PG>594-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-08-04 11:56:12 -0400" MODIFIED_BY="Jenny Bellorini" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kjledsen-Kragh J, Haugen M, Borchrevink CF, Laerum E, Eek M, Mowinckel P, et al</AU>
<TI>Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>338</VL>
<PG>899-902</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKellar-2007" MODIFIED="2008-08-13 07:23:12 -0400" MODIFIED_BY="[Empty name]" NAME="McKellar 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-08-13 07:23:12 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McKellar G, Morrison E, McEntegart A, Hampson R, Tierney A, Mackle R, et l</AU>
<TI>A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>2007</YR>
<VL>66</VL>
<PG>139-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nenonen-1998" MODIFIED="2008-08-13 07:38:42 -0400" MODIFIED_BY="[Empty name]" NAME="Nenonen 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nenonen MT, Helve TA, Rauma AL, Hänninen OO</AU>
<TI>Uncooked, lactobacilli-rich, vegan food and rheumatoid arthritis</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1998</YR>
<VL>37</VL>
<PG>274-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-08-13 07:38:42 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peltonen R, Nenonen M, Helve T, Hänninen O, Toivanen P, Eerola E</AU>
<TI>Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1997</YR>
<VL>36</VL>
<PG>64-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Panush-1983" MODIFIED="2008-08-13 07:40:09 -0400" MODIFIED_BY="[Empty name]" NAME="Panush 1983" YEAR="1983">
<REFERENCE MODIFIED="2008-08-13 07:40:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Panush RS, Carter RL, Katz P, Kowsari B, Longley S, Finnie S</AU>
<TI>Diet therapy for rheumatoid arthritis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1983</YR>
<VL>26</VL>
<PG>462-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-08-04 11:58:39 -0400" MODIFIED_BY="Jenny Bellorini"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Podas-2007" MODIFIED="2008-08-13 07:39:32 -0400" MODIFIED_BY="[Empty name]" NAME="Podas 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-08-13 07:39:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Podas T, Nightingale JMD, Oldham R, Roy S, Sheehan NJ, Mayberry JF</AU>
<TI>Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone</TI>
<SO>Postgraduate Medical Journal</SO>
<YR>2007</YR>
<VL>83</VL>
<PG>128&#8211;31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sarzi_x002d_Puttini-2000" MODIFIED="2008-08-13 07:40:28 -0400" MODIFIED_BY="[Empty name]" NAME="Sarzi-Puttini 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-13 07:40:28 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sarzi-Puttini P, Comi D, Boccassini L, Muzzupappa S, Turiel M, Panni B, et al</AU>
<TI>Diet therapy for rheumatoid arthtitis: a controlled double-blind study of two different dietary regimens</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>2000</YR>
<VL>29</VL>
<PG>302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Sk_x00f6_ldstam-1979" MODIFIED="2008-06-11 01:56:22 -0400" MODIFIED_BY="[Empty name]" NAME="Sköldstam 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sköldstam L, Larsson L, Lindström FD</AU>
<TI>Effects of fasting and lactovegetarian diet on rheumatoid arthritis</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1979</YR>
<VL>8</VL>
<PG>249-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Sk_x00f6_ldstam-2003" MODIFIED="2008-08-13 07:41:17 -0400" MODIFIED_BY="[Empty name]" NAME="Sköldstam 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-13 07:41:17 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hagfors L, Leanderson P, Sköldstam L, Andersson J, Johansson G</AU>
<TI>Antioxidant intake, plasma antioxidants and oxidative stress in a randomized controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis</TI>
<SO>Nutrition Journal</SO>
<YR>2003</YR>
<VL>2</VL>
<PG>41-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sköldstam L, Hagfors L, Johansson G</AU>
<TI>An experimental study of Medieterranean diet intervention for patients with rheumatoid arthritis</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>2003</YR>
<VL>62</VL>
<PG>208-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-de-Laar-1992" NAME="van de Laar 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van de Laar MAFJ, van der Korst JK</AU>
<TI>Food intolerance in rheuatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes</TI>
<SO>Annals of the Rheumatic Disorders</SO>
<YR>1992</YR>
<VL>51</VL>
<PG>298-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-08-15 11:01:45 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Adam-2003" MODIFIED="2008-08-13 07:41:49 -0400" MODIFIED_BY="[Empty name]" NAME="Adam 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-13 07:41:49 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Adam O, Beringer C, Kless T, Lemmen C, Adam A, M. Wiseman M, et al</AU>
<TI>Anti-inflammatory effects of a low arachidonic acid and fish oil in patients with rheumatoid arthritis</TI>
<SO>Rheumatology International</SO>
<YR>2003</YR>
<VL>23</VL>
<PG>27-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gorden-2002" MODIFIED="2008-08-13 07:42:08 -0400" MODIFIED_BY="[Empty name]" NAME="Gorden 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-08-13 07:42:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gorden MM, Thomson EA, Madhok R, Capell HA</AU>
<TI>Can intervention modify adverse lifestyle variables in a rheumatoid population?</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>2002</YR>
<VL>61</VL>
<PG>66-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hafstr_x00f6_m-1988" MODIFIED="2008-08-13 07:42:29 -0400" MODIFIED_BY="[Empty name]" NAME="Hafström 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-08-13 07:42:29 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hafström I, Ringertz B, Gyllenhammar H, Palmblad J, Harms-Ringdahl M</AU>
<TI>Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthtitis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1988</YR>
<VL>31</VL>
<PG>585-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haugen-1990" MODIFIED="2008-08-15 11:01:45 -0400" MODIFIED_BY="[Empty name]" NAME="Haugen 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-08-15 11:01:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haugen M, Fraser T, Førre Ø</AU>
<TI>Diet therapy for the patient with rheumatoid arthritis</TI>
<SO>British Society for Rheumatology</SO>
<YR>1990</YR>
<VL>12</VL>
<PG>1039-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iwashige-2004" MODIFIED="2008-08-13 07:43:02 -0400" MODIFIED_BY="[Empty name]" NAME="Iwashige 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-08-13 07:43:02 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iwashige K, Kouda K, Kouda M, Horiuchi K, Takahashi M, Nagano A,</AU>
<TI>Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis</TI>
<SO>Journal of Physiological Antropology and Applied Human Science</SO>
<YR>2004</YR>
<VL>23</VL>
<PG>19-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karatay-2006" MODIFIED="2008-08-13 07:43:22 -0400" MODIFIED_BY="[Empty name]" NAME="Karatay 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-08-13 07:43:22 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karatay S, Erdem T, Kiziltunc A, Melkoglu M, Yildirim K, Cakir E, et al</AU>
<TI>General or personal diet: the individualized model for diet challenges in patients with rheumatoid arthritis</TI>
<SO>Rheumatology International</SO>
<YR>2006</YR>
<VL>26</VL>
<PG>556-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kjeldsen_x002d_Kragh-1999" MODIFIED="2008-08-13 07:43:44 -0400" MODIFIED_BY="[Empty name]" NAME="Kjeldsen-Kragh 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-08-13 07:43:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kjeldsen-Kragh J</AU>
<TI>Rheumatoid arthritis treated with vegetarian diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>70</VL>
<PG>594-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McDougall-2002" MODIFIED="2008-08-13 07:44:06 -0400" MODIFIED_BY="[Empty name]" NAME="McDougall 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-08-13 07:44:06 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDougall B, Spiller G, Westerdahl J, McDougall M</AU>
<TI>Effects of a very low-fat, vegan diet in subjects with rheumatoid arthirits</TI>
<SO>The Journal of Alternative and Complementary Medicine</SO>
<YR>2002</YR>
<VL>8</VL>
<PG>71-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rauma-1993" MODIFIED="2008-08-13 07:44:32 -0400" MODIFIED_BY="[Empty name]" NAME="Rauma 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-08-13 07:44:32 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rauma AL, Nenonen M, Helve T, Hänninen O</AU>
<TI>Effect of a strict vegan diet on energy and nutrient intakes by Finnish rheumatoid patients</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>47</VL>
<PG>747-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Silverio-2003" MODIFIED="2008-08-13 07:44:50 -0400" MODIFIED_BY="[Empty name]" NAME="Silverio 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-13 07:44:50 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silverio Amancio OM, Alves Chaud DM, Yanaguibashi G, Esteves Hilário MO</AU>
<TI>Copper and zinc intake and serum levels in patients with juvenile rheumatoid arthritis</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>57</VL>
<PG>706-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ski_x00f6_ldstam-1986" MODIFIED="2008-08-13 07:45:15 -0400" MODIFIED_BY="[Empty name]" NAME="Skiöldstam 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-08-13 07:45:15 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skiöldstam L</AU>
<TI>Fasting and vegan diet in rheumatoid arthritis</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1986</YR>
<VL>15</VL>
<PG>219-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sundquist-1982" MODIFIED="2008-08-13 07:45:29 -0400" MODIFIED_BY="[Empty name]" NAME="Sundquist 1982" YEAR="1982">
<REFERENCE MODIFIED="2008-08-13 07:45:29 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sundqvist T, Lindstrøm F, Magnusson KE, Sköldstam L, Stjernström I, Tagesson C</AU>
<TI>Influence of fasting on intestinal permeability and disease activity in patients with rheumatoid arthritis</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1982</YR>
<VL>11</VL>
<PG>33-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-De-Laar-1992" MODIFIED="2008-08-13 07:45:48 -0400" MODIFIED_BY="[Empty name]" NAME="Van De Laar 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-08-13 07:45:48 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van de Laar MA, Aalbers M, Bruins FG, van Dinther-Janssen AC, van der Korst JK, Meijer CJ</AU>
<TI>Food intolerance in rheumatoid arthritis. II Clinical and histological aspects</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>1992</YR>
<VL>51</VL>
<PG>303-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-11 11:27:35 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-11 11:27:35 -0500" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Arnett-1988" MODIFIED="2008-08-13 07:46:35 -0400" MODIFIED_BY="[Empty name]" NAME="Arnett 1988" TYPE="JOURNAL_ARTICLE">
<AU>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al</AU>
<TI>The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>1988</YR>
<VL>31</VL>
<PG>315-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arshad-2007" MODIFIED="2008-07-22 21:31:09 -0400" MODIFIED_BY="[Empty name]" NAME="Arshad 2007" TYPE="JOURNAL_ARTICLE">
<AU>Arshad A, Rashid R, Benjamin K</AU>
<TI>The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism</TI>
<SO>Modern Rheumatology</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>6</NO>
<PG>470-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chiang-2003" MODIFIED="2008-07-22 21:06:36 -0400" MODIFIED_BY="[Empty name]" NAME="Chiang 2003" TYPE="JOURNAL_ARTICLE">
<AU>Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R</AU>
<TI>Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis</TI>
<SO>American Journal of Medicine</SO>
<YR>2003</YR>
<VL>114</VL>
<NO>4</NO>
<PG>283-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" MODIFIED="2008-08-15 11:17:44 -0400" MODIFIED_BY="[Empty name]" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Caroll D, Jenkinson C, Reynholds DJM, Gavanagh DJ, et al</AU>
<TI>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kremers-2004" MODIFIED="2008-08-05 15:08:18 -0400" MODIFIED_BY="Jenny Bellorini" NAME="Kremers 2004" TYPE="JOURNAL_ARTICLE">
<AU>Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE</AU>
<TI>Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>2004</YR>
<VL>50</VL>
<NO>11</NO>
<PG>326-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Metsios-2007" MODIFIED="2008-08-13 07:47:03 -0400" MODIFIED_BY="[Empty name]" NAME="Metsios 2007" TYPE="JOURNAL_ARTICLE">
<AU>Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, et al</AU>
<TI>Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia</TI>
<SO>Rheumatology</SO>
<YR>2007</YR>
<VL>46</VL>
<NO>12</NO>
<PG>1824-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Munro-1997" MODIFIED="2008-07-22 21:08:35 -0400" MODIFIED_BY="[Empty name]" NAME="Munro 1997" TYPE="JOURNAL_ARTICLE">
<AU>Munro R, Capell H</AU>
<TI>Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response</TI>
<SO>Annals of the Rheumatic Diseases</SO>
<YR>1997</YR>
<VL>56</VL>
<NO>5</NO>
<PG>326-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-M_x00fc_ller-2001" NAME="Müller 2001" TYPE="JOURNAL_ARTICLE">
<AU>Müller H, Wilhelmi de Toledo F, Resch K-L</AU>
<TI>Fasting followed by vegetarian diet in patients with rheumatoid rthritis: a systematic review</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>2001</YR>
<VL>30</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rennie-2003" NAME="Rennie 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rennie KL, Hughes J, Lang R, Jebb SA</AU>
<TI>Nutritional management of rheumatoid arthritis: a review of the evidence</TI>
<SO>Journal of Human Nutritional Dietetics</SO>
<YR>2003</YR>
<VL>16</VL>
<PG>97-109</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Solomon-2006" MODIFIED="2008-08-13 07:47:33 -0400" MODIFIED_BY="[Empty name]" NAME="Solomon 2006" TYPE="JOURNAL_ARTICLE">
<AU>Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, et al</AU>
<TI>Patterns of cardiovascular risk in rheumatoid arthritis</TI>
<SO>Annals of Rheumatic Diseases</SO>
<YR>2006</YR>
<VL>65</VL>
<PG>1608-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tugwell-2004" MODIFIED="2008-11-11 11:27:35 -0500" MODIFIED_BY="[Empty name]" NAME="Tugwell 2004" TYPE="BOOK">
<AU>Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G (editors)</AU>
<SO>Evidence-based Rheuamtology</SO>
<YR>2004</YR>
<PB>BMJ Publishing Group</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Uhlig-2005" MODIFIED="2008-08-15 11:16:37 -0400" MODIFIED_BY="[Empty name]" NAME="Uhlig 2005" TYPE="JOURNAL_ARTICLE">
<AU>Uhlig T, Kvien TK</AU>
<TI>Is rheumatoid arthritis disappearing?</TI>
<SO>Annals of Rheumatic Diseases</SO>
<YR>2005</YR>
<VL>64</VL>
<NO>1</NO>
<PG>7-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Uhlig-2007" MODIFIED="2008-07-22 21:14:30 -0400" MODIFIED_BY="[Empty name]" NAME="Uhlig 2007" TYPE="JOURNAL_ARTICLE">
<AU>Uhlig T, Loge JH, Kristiansen IS, Kvien TK</AU>
<TI>Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population</TI>
<SO>Journal of Rheumatology</SO>
<YR>2007</YR>
<VL>34</VL>
<NO>6</NO>
<PG>1241-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-van-Staa--2006" MODIFIED="2008-08-13 07:47:49 -0400" MODIFIED_BY="[Empty name]" NAME="van Staa  2006" TYPE="JOURNAL_ARTICLE">
<AU>van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C</AU>
<TI>Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>2006</YR>
<VL>54</VL>
<PG>3104-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verhagen-1998" MODIFIED="2008-08-13 07:48:07 -0400" MODIFIED_BY="[Empty name]" NAME="Verhagen 1998" TYPE="JOURNAL_ARTICLE">
<AU>Verhagen AP, De Vet HCW, De Bie RA, Kessels AGH, Boers M, Knipschild PG</AU>
<TI>Balneotherapy and quality assessment: interobserver reliabiltiy of the Maastricht criteria list and the need for blinded quality assessment</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1998</YR>
<VL>51</VL>
<PG>335-41</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-11-11 12:45:43 -0500" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-11-11 12:45:43 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-11-11 12:39:02 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Darlington-1986">
<CHAR_METHODS MODIFIED="2008-11-11 12:39:02 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: UNCLEAR<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: UNCLEAR<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: MET (patients blinded)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>Country: UK<BR/>Number: 45<BR/>Age:<BR/>Sex: 89% women</P>
<P>Inclusion criteria: rheumatoid arthritis patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:06 -0400" MODIFIED_BY="[Empty name]">
<P>Both groups started with 2 weeks washout period</P>
<P>Intervention group (diet intervention): during the first week, the patients ate only foods which they tolerated. Other foods were then reintroduced one at a time. At first further foods unlikely to cause intolerance were reintroduced, then foods which often cause intolerance, and finally normal diet.</P>
<P>Control group: 6 weeks with ordinary food before then also proceeding to the diet group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>a) Day and night pain (4-point scale)<BR/>b) Average pain (VAS)<BR/>c) Duration of morning stiffness (minutes)<BR/>d) Grip strength<BR/>e) Number of painful joints</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:38:58 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hafstr_x00f6_m-2001">
<CHAR_METHODS MODIFIED="2008-11-11 12:38:58 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: UNCLEAR<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Sweden<BR/>Number: 66<BR/>Mean age 50 years<BR/>Sex:</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the 1987 ACR criteria<BR/>b) Disease duration at least 2 years<BR/>c) Age between 20 and 69 years<BR/>d) Not tried dietary manipulation earlier<BR/>e) No history of food sensitivity or food allergy<BR/>f) Active disease<BR/>g) Stable doses of NSAIDs, daily dose of oral corticosteroids &lt; 7.5 mg and DMARDs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>For both groups the diet was introduced during an initial week of instruction in the theory and practical preparation of the diet in question by a dietician</P>
<P>Intervention group: the patients ate a vegan diet free from gluten, which contained vegetables, root vegetables, nuts and fruits. Of cereals the diet contained buckwheat, millet, corn, rice and sunflower seeds. Sesame milk was a source of calcium.</P>
<P>Control group: well-balanced diet (non-vegan diet) - 12 weeks with ordinary food</P>
<P>Each patient was allowed to get advice and help in maintaining their respective diets from physicians, dieticians and nurses. Compliance was assessed by dietary intake records.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-05 15:31:42 -0400" MODIFIED_BY="Jenny Bellorini">
<P>Main outcome:<BR/>ACR-20 response criteria</P>
<P>Secondary outcome: <BR/>Radiographic progression</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:38:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hansen-1996">
<CHAR_METHODS MODIFIED="2008-11-11 12:38:52 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: NOT MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Denmark<BR/>Number: 109<BR/>Mean age: 57 years<BR/>Sex: 74.6% women</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the 1988 ARA criteria, including a positive RF<BR/>b) Active disease was defined by at least 2 of the following 3 criteria:<BR/>1) 4 swollen joints<BR/>2) Morning stiffness of 60 minutes or greater<BR/>3) ESR 28 mm/hour</P>
<P>Exclusion criteria:<BR/>Underweight patients and those with severe concomitant disorders</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: experimental diet - 6 months on the Graastener diet. The diet is composed of an energy intake adjusted to obtain near standard BMI, fat content 20% to 30% of total energy intake, 1.5 g protein per kg body weight, 800 g fresh fish per week. If necessary capsules of omega-3 fish oils were given. Nuts and beans were given to increase intake of antioxidants.</P>
<P>Control group: the patients in the control group ate ordinary food for 6 months</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>a) Tender/swollen joints (28-joint count)<BR/>b) Pain intensity (VAS )<BR/>c) Health Assessment Questionnaire (HAQ)<BR/>d) Patients global assessment<BR/>e) Physicians global assessment<BR/>f) Acute phase reactant<BR/>g) X-ray<BR/>h) Duration of morning stiffness<BR/>i) Concominant medication</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:39:27 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haugen-1994">
<CHAR_METHODS MODIFIED="2008-11-11 12:39:27 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: UNCLEAR<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Norway<BR/>Number: 20<BR/>Age: mean 50 years<BR/>Sex: 16 women; 4 men</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the ARA criteria</P>
<P>Active disease was defined by at least 4 of the following 5 criteria:<BR/>1) 6 tender and/or painful joints;<BR/>2) 3 swollen joints;<BR/>3) morning stiffness of 45 minutes or greater;<BR/>4) ESR 28 mm/hour;<BR/>b) stable doses of drug treatment.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: experimental diet comprised an elemental diet, E028, for 3 weeks and 1 week with regular diet. The elemental diet was naturally and artificially flavoured with orange, blackcurrant, pineapple and tomato flavourings from which the patients could choose freely.</P>
<P>Control group: the control group was served a well-mixed and blended soup for 3 weeks. They were served 2 different soups: one was made of meat, cod, shrimps, milk, fresh cream, cream of wheat, corn flour and maltodextrine. The second was made of milk and soy oil, and was flavoured with either orange juice, pineapple juice or blackcurrant squash.</P>
<P>Both soups were prepared in the hospital kitchen and the patients were given a week's supply of frozen soup in portions of 360 kcal every week at the time of the clinical examination.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Main outcome:<BR/>a) Joint count; Ritchie`s articular index<BR/>b) Grip strength<BR/>c) Duration of morning stiffness<BR/>d) Pain (VAS)<BR/>e) ESR, CRP, Hb, albumin and erythrocyte count<BR/>f) Global assessment (5-point scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:40:06 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Holst_x002d_Jensen--1998">
<CHAR_METHODS MODIFIED="2008-11-11 12:40:06 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: UNCLEAR<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:07 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Denmark<BR/>Number: 30<BR/>Median age 49.5 years<BR/>Sex: 80% women</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the 1987 ACR criteria<BR/>b) Disease duration at least 6 months.<BR/>c) Age between 18 and 75 years<BR/>Active disease was defined by at least 3 of the following 4 criteria:<BR/>1) 6 tender and/or painful joints;<BR/>2) 3 swollen joints;<BR/>3) morning stiffness of 45 minutes or greater;<BR/>4) ESR 28 mm/hour;<BR/>d) stable doses of NSAIDs, daily dose of oral corticosteroids &lt; 7.5 mg.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-15 10:05:50 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: the experimental group received a liquid elemental diet for 4 weeks. Water and soda water were allowed. The cartons contained hydrolysed soy protein, 15% of total energy, lipids 30% and carbohydrate 55% of total energy. The daily dosage of diet was calculated from recommended energy intake to sick adults of 30 kcal/kg body weight/day. The participants were allowed to call the nurse if any problem about the diet arose.</P>
<P>Control group: the control group ate their regular food and were requested not to change food habits during the study</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-22 19:57:07 -0400" MODIFIED_BY="[Empty name]">
<P>a) Duration of morning stiffness<BR/>b) Health Assessment Questionnaire (HAQ)<BR/>c) Number of swollen joints<BR/>d) Pain intensity<BR/>e) Joint tenderness<BR/>f) General assessment of health<BR/>g) ESR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:40:48 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kavanagh-1995">
<CHAR_METHODS MODIFIED="2008-11-11 12:40:48 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET 0 to 4 weeks follow-up; NOT MET 8 to 24 weeks follow-up<BR/>Intention-to-treat: UNCLEAR<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>Country: England<BR/>Number: 47<BR/>Mean age: 45.6 years<BR/>Sex: 78.7% women</P>
<P>Inclusion criteria: ARA criteria</P>
<P>Exclusion criteria: use of corticosteroids and disease-modifying anti-rheumatic drugs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: 4 weeks with elemental 028 (E028) and foods like chicken, fish, rice, carrots, runner beans and bananas. This period was followed by reintroduction of food. First foods unlikely to cause intolerance were introduced, followed by foods which more often cause intolerance. Foods were introduced one at a time at intervals no shorter than 2 days. If a foodstuff was suspected to cause worsening of joint pain or stiffness, it was eliminated from the diet.</P>
<P>Control group: the patients in this group ingested 2 sachets of E028 daily in addition to their normal diet. They were encouraged to use the solution as a substitute.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-22 20:00:37 -0400" MODIFIED_BY="[Empty name]">
<P>a) Duration of morning stiffness<BR/>b) Grip strength<BR/>c) Functional score<BR/>d) Ritchie articular index <BR/>e) Thermographic joint score<BR/>f) ESR and CRP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:41:19 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991">
<CHAR_METHODS MODIFIED="2008-11-11 12:41:19 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: MET<BR/>Concealment of allocation: MET<BR/>Co-interventions: MET<BR/>Losses to follow-up: NOT MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Norway<BR/>Number: 53<BR/>Mean age 54.5 years<BR/>Sex: 85% women</P>
<P>Inclusion criteria: rheumatoid arthritis patients with 3 of the 4 following:<BR/>a) 6 tender and/or painful joints;<BR/>b) 3 swollen joints;<BR/>c) morning stiffness of 45 minutes or greater;<BR/>d) ESR 28 mm/hour.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: fasting for 7 to 10 days. The dietary intake during the fast consisted of herbal teas, garlic, vegetable broth, decoction of potatoes and parsley and juice extracts from carrots, beets and celery. Fruit juices were not allowed. After the fast the patients reintroduced a food item every second day. The patients were asked to have a diet free from gluten, meat, fish, eggs, dairy products, refined sugar or citrus fruits during the first 3.5 months. Salt, strong spices, preservatives, alcohol, tea and coffee were not allowed. After the first 3.5 months the patients were allowed to reintroduce milk, dairy products and gluten.</P>
<P>Control group: the patients stayed for 4 weeks at a convalescent home and were recommended to eat ordinary food throughout the study</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-22 20:03:17 -0400" MODIFIED_BY="[Empty name]">
<P>a) Global assessment (5-point scale)<BR/>b) Ritchie index<BR/>c) Number of tender and swollen joints<BR/>d) Pain (VAS)<BR/>e) Health Assessment Questionnaire (HAQ)<BR/>f) Duration of morning stiffness</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:42:18 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McKellar-2007">
<CHAR_METHODS MODIFIED="2008-11-11 12:41:56 -0500" MODIFIED_BY="[Empty name]">
<P>CCT<BR/>Random generation of allocation: NOT MET<BR/>Concealment of allocation: NOT MET<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: UNCLEAR<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Scotland, UK<BR/>Number: 130<BR/>Mean age: 54 years<BR/>Sex: 100% women</P>
<P>Inclusion criteria: rheumatoid arthritis patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-11 12:42:18 -0500" MODIFIED_BY="[Empty name]">
<P>Intervention group: a 6-week cookery course (with emphasis on a Mediterranean-type diet) delivered by nutritionists. The patients attended a weekly 2-hour cookery class and received a folder with written information on a Mediterranean-type diet, healthy eating and recipes.</P>
<P>Control group: control patients received readily available written information on healthy eating only.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>a)Tender and swollen joints count<BR/>b) Patient global and pain score (VAS)<BR/>c) Duration of early morning stiffness (EMS)<BR/>d) DAS28<BR/>e) HAQ score<BR/>f) Erythrocyte sedimentation rate (ESR)<BR/>g) C reactive protein<BR/>h) Interleukin 6 (IL6)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:42:57 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nenonen-1998">
<CHAR_METHODS MODIFIED="2008-11-11 12:42:32 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:08 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Finland<BR/>Number: 43<BR/>Mean age: 53 years<BR/>Sex: 86% wome</P>
<P>Inclusion criteria: rheumatoid arthritis patients diagnosed with the ARA criteria:<BR/>a) Chronic and active RA (Steinbrocker's functional class II-III)<BR/>b) &gt; 5 tender and/or painful joints<BR/>c) &gt; 3 swollen joints<BR/>d) CRP &gt; 10 ml/l<BR/>e) ESR &gt; 20 mm/hour</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-11 12:42:57 -0500" MODIFIED_BY="[Empty name]">
<P>Intervention group: 3 months with living food, an uncooked vegan diet rich in lactobacilli. The patients received all components of their diet from a specialised kitchen in packed forms. The diet does not contain any animal products, raffinated substances or added salt. The items were soaked, sprouted, fermented, blended or dehydrated. Compliance was followed by daily interviews, dietary records and by analysing their daily urinary sodium excretion.</P>
<P>Control group: the patients in this group ate an ordinary diet in their homes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-06 14:33:24 -0400" MODIFIED_BY="Jenny Bellorini">
<P>a) Composite index after Paulus<BR/>b) DAS<BR/>c) Subjective assessments of rheumatic pain, swelling of joints, morning stiffness, ability to move and general impression on modified VAS scales</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:43:42 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Panush-1983">
<CHAR_METHODS MODIFIED="2008-11-11 12:43:12 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: MET<BR/>Concealment of allocation: MET<BR/>Co-interventions: MET<BR/>Losses to follow-up: NOT MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:09 -0400" MODIFIED_BY="[Empty name]">
<P>Country: USA<BR/>Number: 33<BR/>Mean age: 55 years<BR/>Sex: 34.6 % women</P>
<P>Inclusion criteria: rheumatoid arthritis patients with at least 3 of the following:<BR/>a) 6 tender and/or painful joints;<BR/>b) 3 swollen joints;<BR/>c) morning stiffness of 45 minutes or greater;<BR/>d) ESR 28 mm/hour.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:09 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: experimental diet - during a 10-week intervention period the patients were served a diet free from: dairy products, sardines, turkey, red meat, tomatoes, fruits, alcohol, hot spices, herbs, garlic, vinegar and additives. Fish was permitted. Of other food categories they were only allowed to eat egg whites, vegetable oil, soybean margarine, oatmeal, cream of wheat or grits, sugar, maple and corn syrup, coffee, non-herb tea and soda water.</P>
<P>Control group: placebo diet - during a 10-week intervention period this group was served a diet free from: sour cream, ice milk, cheddar cheese, turkey, cabbage, brussel sprouts, cauliflower, bananas, strawberries, corn flakes, colas and vanilla.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-11 12:43:42 -0500" MODIFIED_BY="[Empty name]">
<P>a) Duration of morning stiffness<BR/>b) Number of tender joints<BR/>c) Number of swollen joints<BR/>d) Grip strength<BR/>e) Walk time 15 metres<BR/>f) Patient assessment (5-point scale)<BR/>g) Examiner assessment (5-point scale)</P>
<P>The authors note that 183 variables were analysed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:44:07 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Podas-2007">
<CHAR_METHODS MODIFIED="2008-11-11 12:43:49 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:09 -0400" MODIFIED_BY="[Empty name]">
<P>Country: UK<BR/>Number: 30<BR/>Mean age: 50 years<BR/>Sex: 73% women</P>
<P>Inclusion criteria: patients with newly diagnosed or established active rheumatoid arthritis (using the revised ARA criteria). Active rheumatoid arthritis was defined by any combination of 3 or more of the following criteria: 3 or more swollen joints, 6 or more tender joints, morning stiffness of longer than 45 minutes and an erythrocyte sedimentation rate (ESR) of more than 28 mm in the first hour.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-11-11 12:44:07 -0500" MODIFIED_BY="[Empty name]">
<P>Intervention group: liquid elemental diet E028 (86 kcal and 2.5 g protein/100 ml) of orange and pineapple flavour as their only source of nutrition for 2 weeks and free access to bottled water.</P>
<P>Control group: oral prednisolone (15 mg) was given daily for 2 weeks while the patients ate a normal diet.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:09 -0400" MODIFIED_BY="[Empty name]">
<P>ACR-20 response criteria were defined as primary end point</P>
<P>Secondary outcomes included:<BR/>a) duration of morning stiffness (EMS);<BR/>b) pain on a 10 cm VAS scale;<BR/>c) the Ritchie articular index (RAI) which grades joint tenderness (0 to 3) over 63 joints;<BR/>d) 16 swollen joint score (63 joints);<BR/>e) HAQ;<BR/>f) global patient and physician assessment scores on a 5-grade scale (much worse, worse, same, better, much better);<BR/>g) ESR, C-reactive protein (CRP).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:44:21 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sarzi_x002d_Puttini-2000">
<CHAR_METHODS MODIFIED="2008-11-11 12:44:21 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: UNCLEAR<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:09 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Italy<BR/>Number: 50<BR/>Mean age: 50 years<BR/>Sex: 78% women</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the 1987 ACR criteria<BR/>b) Functional class I to III (Steinbroker)<BR/>c) Age between 25 and 70 years<BR/>d) Stable dosage and anti-rheumatic therapy for at least 12 weeks prior the study entry</P>
<P>Active disease was defined by at least 4 of the following 5 criteria:<BR/>1) 5 tender and/or painful joints;<BR/>2) 3 swollen joints;<BR/>3) morning stiffness of 45 minutes or greater;<BR/>4) ESR 30 mm/hour;<BR/>5) VAS &gt;/= 4.</P>
<P>Patients were allowed to continue pre-study therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: experimental diet contained hypoallergenic foods such as rice, cornmeal, cornbread, hydrolysed milk, fresh pineapple and cooked apple. Allergenic foods such as wheat meal, eggs, milk, strawberries, acid fruit. tomato, chocolate, crustaceans, and dried fruit were deprived. All canned or transformed foods together with spices and aromatic plants were excluded.</P>
<P>Control group: the control group ate a diet which included common allergenic foods but restricted the intake of nourishment containing a lot of saturated fatty acids</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>a) Morning stiffness<BR/>b) Health Assessment Questionnaire (HAQ)<BR/>c) Number of tender and swollen joints<BR/>d) Pain (VAS)<BR/>e) Ritchies index<BR/>f) Investigators' and patients' global assessment of disease (VAS)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:44:50 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sk_x00f6_ldstam-1979">
<CHAR_METHODS MODIFIED="2008-11-11 12:44:50 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: UNCLEAR<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: UNCLEAR<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Sweden<BR/>Number: 26<BR/>Mean age: 53 years<BR/>Sex: 73% women</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the ARA criteria<BR/>b) Low-moderate inflammatory activity<BR/>c) Daily use of NSAIDs</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: fasting and vegetarian diet - patients underwent a period of 7 to 10 days of fasting. After fasting a plain lacto-vegetarian diet was instituted. The patients were instructed for 1 week and were recommended to continue the diet for 9 weeks. No animal or fish protein was allowed. Yoghurt was allowed freely, but fresh milk and cream were discouraged. Alcohol, tobacco, coffee and tea were not allowed. The patients were recommended to be restrictive with salt, sugar and white flour. Grain products were allowed in small quantities.<BR/>All subjects were counselled weekly by a dietician.</P>
<P>Control group: 9 weeks with ordinary diet</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>a) Pain rating scale (4-point scale)<BR/>b) Stiffness rating scale (4-point scale)<BR/>c) Body weight<BR/>d) Daily dose of NSAIDS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:45:15 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sk_x00f6_ldstam-2003">
<CHAR_METHODS MODIFIED="2008-11-11 12:45:15 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: MET<BR/>Concealment of allocation: MET<BR/>Co-interventions: MET<BR/>Losses to follow-up: MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: NOT MET<BR/>Blinding of provider or patient: NOT MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Country: Sweden<BR/>Number: 56<BR/>Mean age: 58.5 years<BR/>Sex: 82% women</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the 1987 ACR criteria<BR/>b) Disease duration at least 2 years.<BR/>c) Stable disease activity</P>
<P>Exclusion criteria:<BR/>DMARDs dose unchanged &gt; 3 months, corticosteroids &gt; 4 weeks, NSAIDS &gt; 10 days.<BR/>Daily dose of oral corticosteroids &lt; 12.5 mg<BR/>Baseline DAS28 &gt; 2.0<BR/>No other conditions<BR/>Not vegetarians or patients already living on a Mediterranean-like diet</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: a Cretan Mediterranean Diet (MD) according to de Lorgeril was tested. During the 3-week Outpatient-based Rehabilitation Programme (ORP) they were served a MD from the hospital canteen. Six lessons of MD food and cooking were provided by a dietician. For the rest of the study (9 weeks at home) written instructions and recipes were given. Some food items (oils, margarine, frozen vegetables and tea) were supplied free. The dietician was available for telephone consultations. No recommendations were given about alcohol consumption.</P>
<P>Control group: during the 3-week ORP they were served ordinary hospital food. For the rest of the study (9 weeks) they were advised to not experiment with the diet</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Main outcomes:<BR/>a) DAS 28<BR/>b) Health Assessment Questionnaire (HAQ)<BR/>c) SF-36<BR/>d) Daily dose of NSAIDS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-11-11 12:45:43 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-de-Laar-1992">
<CHAR_METHODS MODIFIED="2008-11-11 12:45:43 -0500" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Random generation of allocation: UNCLEAR<BR/>Concealment of allocation: UNCLEAR<BR/>Co-interventions: MET<BR/>Losses to follow-up: NOT MET<BR/>Intention-to-treat: MET<BR/>Outcome assessment: MET<BR/>Blinding of provider or patient: MET</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Country: The Netherlands<BR/>Number: 94<BR/>Mean age: 58 years<BR/>Sex: 70% women</P>
<P>Inclusion criteria:<BR/>a) Rheumatoid arthritis according to the 1987 ACR criteria, including a positive RF<BR/>b) Disease onset after 16 years of age</P>
<P>Active disease was defined by at least 3 of the following 4 criteria:<BR/>1) 5 tender and/or painful joints;<BR/>2) 2 swollen joints;<BR/>3) morning stiffness of 45 minutes or greater;<BR/>4) ESR 28 mm/hour;<BR/>d) stable doses of NSAIDs, daily dose of oral corticosteroids &lt; 10 mg/day.</P>
<P>Exclusion criteria:<BR/>Patients in functional class 4 according to Steinbrocker</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Intervention group: experimental diet - 4 weeks with the patient's normal diet, 4 weeks with an elemental diet which is potentially free from allergenics. It contained 16 g free aminoacids, 13.6 g fat and 55 g lactose per 90 g. The patients were allowed to consume 3 apples, tea, allergen-free chewing gum and sugar per day. For the remaining 4 weeks the patients returned to their usual diets.</P>
<P>Control group: the patients in the control group received milk allergens in the second 4-week period. It contained 20 g lactoprotein, 16 g fat and 48 g lactose per 90 g</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-22 20:31:57 -0400" MODIFIED_BY="[Empty name]">
<P>Main outcomes:<BR/>a) Duration of morning stiffness<BR/>b) Number of tender joints<BR/>c) Number of swollen joints<BR/>d) Pain accoring to Ritchie index<BR/>e) Global assessment and fatigue (VAS)<BR/>f) Body weight<BR/>g) Grip strength<BR/>h) 30 feet walking time</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Silver</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ACR = American College of Rheumatology</P>
<P>BMI = Body mass index</P>
<P>CCT = Controlled clinical trial</P>
<P>CRP = C-reactive protein</P>
<P>DAS = Disease activity state</P>
<P>ESR = Erythrocyte sedimentation rate</P>
<P>HAQ = Health assessment questionnaire</P>
<P>RCT = Randomised controlled trial</P>
<P>RF = Rheumatoid factor</P>
<P>SF-36 =Medical outcomes study short form survey, 36 items</P>
<P>VAS = Visual analogue scale</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Adam-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not relevant intervention and outcome</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gorden-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hafstr_x00f6_m-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not relevant outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haugen-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Iwashige-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karatay-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McDougall-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rauma-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Silverio-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ski_x00f6_ldstam-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sundquist-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-De-Laar-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-13 07:08:10 -0400" MODIFIED_BY="[Empty name]">
<P>Not a RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT = randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-08-06 14:33:11 -0400" MODIFIED_BY="Jenny Bellorini">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-08-06 14:33:11 -0400" MODIFIED_BY="Jenny Bellorini" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Darlington-1986">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hafstr_x00f6_m-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hansen-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Haugen-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Holst_x002d_Jensen--1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kavanagh-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-06 14:33:11 -0400" MODIFIED_BY="Jenny Bellorini" RESULT="YES" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991">
<DESCRIPTION>
<P>Graded as 'met' after correspondence with the author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-McKellar-2007">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nenonen-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-21 13:23:18 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Panush-1983">
<DESCRIPTION>
<P>MET</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Podas-2007">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sarzi_x002d_Puttini-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sk_x00f6_ldstam-1979">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-11 04:09:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sk_x00f6_ldstam-2003">
<DESCRIPTION>
<P>graded as 'met' after correspondence with the author</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-van-de-Laar-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-11-13 13:09:01 -0500" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-10-25 11:30:30 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-08-15 10:16:22 -0400" MODIFIED_BY="[Empty name]">Clinical relevance table - 7 to 10 days fasting and 13 months vegetarian diet versus usual diet</TITLE>
<TABLE COLS="7" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome (scale)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>No. of patients</P>
<P>(no. of studies)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Control Baseline mean</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Wt Absolute change (95%CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Relative change(%)</P>
<P>(95%CI)</P>
</TH>
<TH>
<P>Statistical Significance</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Level of evidence</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pain VAS (0 to 10, 0 is best)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.73</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19% lower (-16, -36)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>43 % lower (-36, -82)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Morning stiffness (hours)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.13 hours</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-1.08 hours less [-2.23, 0.07]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 % less (-3, 100)</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>HAQ score (0 to 3, 0 is best)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0.92</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2% (-11, 16)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8% lower (-37, 52)</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Body weight</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>66.9 kg</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.5 kg fewer</P>
<P>(-8.8 to 5.8)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 lower (-13, 9)</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-11-10 00:20:13 -0500" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-08-14 07:38:08 -0400" MODIFIED_BY="[Empty name]">Clinical relevance table - 12 weeks Mediterranean diet versus usual diet</TITLE>
<TABLE COLS="7" ROWS="5">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome (scale)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>No. of patients</P>
<P>(no. of studies)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Control Baseline mean</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Wt Absolute Change</P>
<P>(95%CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Relative Change(%)</P>
</TH>
<TH VALIGN="TOP">
<P>Statistical Significance</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Level of evidence</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Pain VAS (0 to 100, 0 is best)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>31</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14% lower (-24, -4)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>45% lower (-77, -13)</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Morning stiffness (minutes)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>64</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26 minutes less [-58, 6]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40% lower (-91, 9)</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>HAQ score (0 to 3, 0 is best)</P>
</TD>
<TD>
<P>51</P>
<P>(1)</P>
</TD>
<TD>
<P>0.8</P>
</TD>
<TD>
<P>7% lower (-16, 3)</P>
</TD>
<TD>
<P>25% lower (-60, 10)</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Body weight (kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>73 kg</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 kg more (-4, 11]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5% more (-5, 14)</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2008-11-10 00:20:13 -0500" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2008-08-15 10:16:59 -0400" MODIFIED_BY="[Empty name]">Clinical relevance table - 4 weeks elemental diet versus usual diet</TITLE>
<TABLE COLS="7" ROWS="3">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome (scale)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>No. of patients</P>
<P>(no. of studies)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Control Baseline mean</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Wt Absolute Change</P>
<P>(95%CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Relative Change(%)</P>
</TH>
<TH>
<P>Statistical Significance</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Level of evidence</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Functional score (no scale reported)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>45</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9.32</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>can not be calculated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9% less (-46, 30)</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P>Body weight (kg)</P>
</TD>
<TD>
<P>45</P>
<P>(1)</P>
</TD>
<TD>
<P>67 kg</P>
</TD>
<TD>
<P>4 kg less (-11, 3]</P>
</TD>
<TD>
<P>6% lower (-17, 5)</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2008-11-13 13:09:01 -0500" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2008-10-25 11:03:22 -0400" MODIFIED_BY="[Empty name]">Clinical relevance table - 12 months vegan (gluten free) diet versus usual diet</TITLE>
<TABLE COLS="8" ROWS="2">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome (scale)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>No. of patients</P>
<P>(no. of studies)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Control baseline</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Absolute change</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Relative % change*</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>NNT(B) or NNT(H )</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Statistical significance</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>Level of evidence</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20% improvement in signs and symptoms</P>
<P>(ACR 20)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4%</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>34% (13, 48)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>800% (0, 6300)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 (2, 105)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Yes</P>
</TD>
<TD VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2008-10-25 11:45:36 -0400" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2008-08-15 10:17:52 -0400" MODIFIED_BY="[Empty name]">Clinical relevance table - 20 weeks hypoallergenic diet versus well-balanced diet</TITLE>
<TABLE COLS="7" ROWS="4">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Outcome (scale)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>No. of patients</P>
<P>(no. of studies)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Control Baseline mean</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Wt Absolute Change (95%CI)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Relative Change(%) (95%CI)</P>
</TH>
<TH VALIGN="TOP">
<P>Statistical Significance</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Level of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>Pain</P>
<P>VAS (0 to 100, 0 is best)</P>
</TD>
<TD VALIGN="TOP">
<P>42</P>
<P>(1)</P>
</TD>
<TD VALIGN="TOP">
<P>44</P>
</TD>
<TD VALIGN="TOP">
<P>3% (-13, 8)</P>
</TD>
<TD VALIGN="TOP">
<P>6 (-30, 17)</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
<TD VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Morning stiffness (minutes)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>42</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 minutes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 minutes less [-28, 17]</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10% less (-33, 54)</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Body weight (kg)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>42</P>
<P>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>70 kg</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 kg more (-7, 10)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2% more (-10, 14)</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Silver</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-10 00:45:29 -0500" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-08-15 10:37:54 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>7 to 10 days fasting followed by vegetarian diet vs ordinary diet</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.1961501127751415" CI_START="-2.3161501127751416" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.06" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2008-08-15 10:37:01 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.09814538142272805" Q="0.0" RANDOM="NO" SCALE="2.595510903112159" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="1.6539120623271828">
<NAME>Pain (0 to 10) 3 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.1961501127751415" CI_START="-2.3161501127751416" EFFECT_SIZE="-1.06" ESTIMABLE="YES" MEAN_1="2.64" MEAN_2="3.7" ORDER="44" SD_1="1.98" SD_2="1.75" SE="0.6409046914552988" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3198250781867955" CI_START="-0.4598250781867954" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2008-08-15 10:36:33 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.724878564905172" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="0.3519462615282584">
<NAME>Physical function (HAQ, 0 to 3) 3 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3198250781867955" CI_START="-0.4598250781867954" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.91" MEAN_2="0.98" ORDER="45" SD_1="0.65" SD_2="0.5" SE="0.1988940007376084" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.006771607256836454" CI_START="-1.7067716072568366" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8500000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2008-08-15 10:33:18 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.05183842008086512" Q="0.0" RANDOM="NO" SCALE="2.250489884351816" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="1.9444731510105173">
<NAME>Morning stiffness (hrs) 3 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.006771607256836454" CI_START="-1.7067716072568366" EFFECT_SIZE="-0.8500000000000001" ESTIMABLE="YES" MEAN_1="1.23" MEAN_2="2.08" ORDER="46" SD_1="1.42" SD_2="1.11" SE="0.43713640353340244" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.7935186102775207" CI_START="-10.593518610277531" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.4000000000000057" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2008-08-15 10:33:27 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.35425246084348694" Q="0.0" RANDOM="NO" SCALE="10.747714613056853" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="0.9263724622767192">
<NAME>Body weight (kg) 3 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.7935186102775207" CI_START="-10.593518610277531" EFFECT_SIZE="-3.4000000000000057" ESTIMABLE="YES" MEAN_1="63.5" MEAN_2="66.9" ORDER="47" SD_1="10.8" SD_2="10.6" SE="3.670229997601529" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.1776234567858137" CI_START="-2.9776234567858135" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8999999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2008-08-15 10:37:21 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.3958638196737533" Q="0.0" RANDOM="NO" SCALE="3.2670441893017523" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="0.8490314163159256">
<NAME>Pain change (0 to 10) 9 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1776234567858137" CI_START="-2.9776234567858135" EFFECT_SIZE="-0.8999999999999999" ESTIMABLE="YES" MEAN_1="-1.2" MEAN_2="-0.3" ORDER="48" SD_1="3.2" SD_2="2.1" SE="1.0600314460744393" STUDY_ID="STD-Sk_x00f6_ldstam-1979" TOTAL_1="15" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.6873509175729737" CI_START="-3.087350917572974" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.7" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2008-08-15 10:37:12 -0400" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.5655043490196499" Q="0.0" RANDOM="NO" SCALE="3.4324328391911947" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="10" UNITS="" WEIGHT="99.99999999999999" Z="0.5746850113567776">
<NAME>Stiffness change (0 to 10) 9 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.6873509175729737" CI_START="-3.087350917572974" EFFECT_SIZE="-0.7" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="0.5" ORDER="49" SD_1="2.8" SD_2="3.1" SE="1.2180585645471513" STUDY_ID="STD-Sk_x00f6_ldstam-1979" TOTAL_1="15" TOTAL_2="10" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-1.5672194202643999" CI_START="-4.8327805797356005" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.2" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2008-08-15 10:34:11 -0400" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="1.2241964520153008E-4" Q="0.0" RANDOM="NO" SCALE="5.010655363558759" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="10" UNITS="" WEIGHT="100.0" Z="3.8412293901387495">
<NAME>Body weight (kg) change 9 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.5672194202643999" CI_START="-4.8327805797356005" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-2.6" MEAN_2="0.6" ORDER="50" SD_1="2.1" SD_2="2.0" SE="0.8330666239863411" STUDY_ID="STD-Sk_x00f6_ldstam-1979" TOTAL_1="15" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.1636013443943436" CI_START="-3.6163986556056567" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.8900000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-08-15 10:37:54 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.0318969981680459" Q="0.0" RANDOM="NO" SCALE="4.29637443085379" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="2.1456990358238817">
<NAME>Pain (0 to 10) 13 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.1636013443943436" CI_START="-3.6163986556056567" EFFECT_SIZE="-1.8900000000000001" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="5.49" MODIFIED="2008-05-13 09:03:54 -0400" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="2.69" SD_2="2.44" SE="0.880831826106637" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.340134981089419" CI_START="-0.4801349810894191" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.07000000000000006" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2008-08-15 10:37:30 -0400" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.7379888116029064" Q="0.0" RANDOM="NO" SCALE="0.6739989390374687" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="0.3345178666627601">
<NAME>Physical function (HAQ, 0 to 3) 13 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.340134981089419" CI_START="-0.4801349810894191" EFFECT_SIZE="-0.07000000000000006" ESTIMABLE="YES" MEAN_1="0.98" MEAN_2="1.05" ORDER="52" SD_1="0.62" SD_2="0.6" SE="0.20925638650736003" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.07053097132498398" CI_START="-2.230530971324984" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.08" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2008-08-15 10:34:42 -0400" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.0657957899680181" Q="0.0" RANDOM="NO" SCALE="2.3207454489026516" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.00000000000001" Z="1.839812361474752">
<NAME>Morning stiffness (hrs) 13 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.07053097132498398" CI_START="-2.230530971324984" EFFECT_SIZE="-1.08" ESTIMABLE="YES" MEAN_1="1.65" MEAN_2="2.73" ORDER="53" SD_1="1.64" SD_2="1.78" SE="0.5870163841785999" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.795979772897155" CI_START="-8.795979772897155" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2008-08-15 10:36:10 -0400" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.6869818900746625" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="100.0" Z="0.40295423895379856">
<NAME>Body weight (kg) 13 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.795979772897155" CI_START="-8.795979772897155" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="65.4" MEAN_2="66.9" ORDER="54" SD_1="11.1" SD_2="10.6" SE="3.722507061582209" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-11-10 00:45:29 -0500" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Vegan diet vs ordinary diet.</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="64.29800508983335" CI_START="1.2358779978460492" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="8.914285714285715" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="1.80819749871089" LOG_CI_START="0.09197560062544421" LOG_EFFECT_SIZE="0.9500865496681672" METHOD="MH" MODIFIED="2008-08-15 10:39:00 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.030003786218315998" Q="0.0" RANDOM="NO" SCALE="100.81633744908991" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="26" WEIGHT="100.0" Z="2.170040391190513">
<NAME>Response rate ACR20 criteria 12 months follow-up</NAME>
<GROUP_LABEL_1>Vegan diet</GROUP_LABEL_1>
<GROUP_LABEL_2>Ordinary diet</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours usual diet</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours vegan diet</GRAPH_LABEL_2>
<DICH_DATA CI_END="64.29800508983335" CI_START="1.2358779978460492" EFFECT_SIZE="8.914285714285715" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="1" LOG_CI_END="1.80819749871089" LOG_CI_START="0.09197560062544421" LOG_EFFECT_SIZE="0.9500865496681672" ORDER="57" O_E="0.0" SE="1.008117238370799" STUDY_ID="STD-Hafstr_x00f6_m-2001" TOTAL_1="35" TOTAL_2="26" VAR="1.0163003663003662" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-08-15 10:39:31 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Elemental diet vs ordinary diet.</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.7665792906578837" CI_START="-4.366579290657885" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2008-08-15 10:39:24 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6602059360299891" Q="0.0" RANDOM="NO" SCALE="4.7764756760311835" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="21" UNITS="" WEIGHT="100.0" Z="0.4396288599945355">
<NAME>Function 4 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.7665792906578837" CI_START="-4.366579290657885" EFFECT_SIZE="-0.8000000000000007" ESTIMABLE="YES" MEAN_1="9.7" MEAN_2="10.5" ORDER="55" SD_1="6.3" SD_2="5.9" SE="1.819716749282439" STUDY_ID="STD-Kavanagh-1995" TOTAL_1="24" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.321406935215279" CI_START="-11.121406935215276" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.8999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2008-08-15 10:39:31 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.28982754754945084" Q="0.0" RANDOM="NO" SCALE="11.874283346710302" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="21" UNITS="" WEIGHT="100.0" Z="1.0585000413743249">
<NAME>Body weight (kg) 4 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.321406935215279" CI_START="-11.121406935215276" EFFECT_SIZE="-3.8999999999999986" ESTIMABLE="YES" MEAN_1="62.9" MEAN_2="66.8" ORDER="56" SD_1="10.4" SD_2="13.8" SE="3.684458996275857" STUDY_ID="STD-Kavanagh-1995" TOTAL_1="24" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-08-15 10:40:46 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Mediterranean diet vs ordinary diet</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="-4.370212051578902" CI_START="-23.629787948421097" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-14.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2008-08-15 10:40:33 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.004379636830690009" Q="0.0" RANDOM="NO" SCALE="27.520852719723216" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="2.849439253546569">
<NAME>Pain (0 to 100) 12 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-4.370212051578902" CI_START="-23.629787948421097" EFFECT_SIZE="-14.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="34.0" ORDER="59" SD_1="13.0" SD_2="21.0" SE="4.913247398615299" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.08099244403877182" CI_START="-0.48099244403877195" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.20000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2008-08-15 10:40:46 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.16300689216483283" Q="0.0" RANDOM="NO" SCALE="0.5888218344553405" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="25" UNITS="" WEIGHT="99.99999999999999" Z="1.3950296715235626">
<NAME>Function (HAQ, 0 to 3) 12 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.08099244403877182" CI_START="-0.48099244403877195" EFFECT_SIZE="-0.20000000000000007" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.8" ORDER="60" SD_1="0.4" SD_2="0.6" SE="0.14336612624272915" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="26" TOTAL_2="25" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.076413928846769" CI_START="-58.07641392884677" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-26.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2008-08-15 10:39:55 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.1121333162218431" Q="0.0" RANDOM="NO" SCALE="76.46684286473207" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="1.5886770793979939">
<NAME>Morning stiffness (min) 12 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.076413928846769" CI_START="-58.07641392884677" EFFECT_SIZE="-26.0" ESTIMABLE="YES" MEAN_1="44.0" MEAN_2="70.0" ORDER="61" SD_1="52.0" SD_2="64.0" SE="16.36581803638303" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="10.57292310400684" CI_START="-3.9729231040068163" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.3000000000000114" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2008-08-15 10:40:06 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.3738366632371172" Q="0.0" RANDOM="NO" SCALE="15.6809816710585" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="25" UNITS="" WEIGHT="100.0" Z="0.8893097117194723">
<NAME>Body weight (kg) 12 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="10.57292310400684" CI_START="-3.9729231040068163" EFFECT_SIZE="3.3000000000000114" ESTIMABLE="YES" MEAN_1="75.9" MEAN_2="72.6" ORDER="62" SD_1="13.5" SD_2="13.0" SE="3.710743238842508" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="26" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-08-15 10:49:12 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Graastener diet vs normal diet</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.08890091470434536" CI_START="-0.8889009147043454" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.4" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2008-08-15 10:48:59 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.10880943003646114" Q="0.0" RANDOM="NO" SCALE="1.0989840384560006" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="45" UNITS="" WEIGHT="100.0" Z="1.6035674514745466">
<NAME>Change in VAS pain 6 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.08890091470434541" CI_START="-0.8889009147043454" EFFECT_SIZE="-0.4" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="0.2" ORDER="63" SD_1="1.2" SD_2="1.0" SE="0.24944382578492943" STUDY_ID="STD-Hansen-1996" TOTAL_1="36" TOTAL_2="45" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.20864313590814856" CI_START="-0.22864313590814858" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.01" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2008-08-15 10:48:52 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.9285715917850852" Q="0.0" RANDOM="NO" SCALE="0.5461729978733313" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="45" UNITS="" WEIGHT="100.0" Z="0.08964214570007953">
<NAME>Change in function (HAQ, 0 to 3) 6 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.20864313590814856" CI_START="-0.22864313590814858" EFFECT_SIZE="-0.01" ESTIMABLE="YES" MEAN_1="-0.02" MEAN_2="-0.01" ORDER="64" SD_1="0.4" SD_2="0.6" SE="0.1115546702045434" STUDY_ID="STD-Hansen-1996" TOTAL_1="36" TOTAL_2="45" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="17.473572762256406" CI_START="-23.473572762256406" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.03" MODIFIED="2008-08-15 10:49:12 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.7739636048871652" Q="0.0" RANDOM="NO" SCALE="27.520852719723216" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="45" UNITS="" WEIGHT="100.00000000000001" Z="0.28719422945368406">
<NAME>Change in morning stiffness (min) 6 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.473572762256406" CI_START="-23.473572762256406" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-1.0" ORDER="65" SD_1="41.0" SD_2="53.0" SE="10.445892334629276" STUDY_ID="STD-Hansen-1996" TOTAL_1="36" TOTAL_2="45" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-08-15 10:50:49 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Hypoallergenic diet vs a well-balanced diet</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.734459624050649" CI_START="-13.334459624050643" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.799999999999997" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2008-08-15 10:50:18 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6024034291921918" Q="0.0" RANDOM="NO" SCALE="15.267287626711902" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="21" UNITS="" WEIGHT="100.0" Z="0.520947381504318">
<NAME>Pain VAS (0 to 100) 6 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.734459624050649" CI_START="-13.334459624050643" EFFECT_SIZE="-2.799999999999997" ESTIMABLE="YES" MEAN_1="37.6" MEAN_2="40.4" ORDER="66" SD_1="12.3" SD_2="21.5" SE="5.37482306162007" STUDY_ID="STD-Sarzi_x002d_Puttini-2000" TOTAL_1="22" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="17.190225170413257" CI_START="-27.590225170413248" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.199999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2008-08-15 10:50:32 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6489723587666214" Q="0.0" RANDOM="NO" SCALE="34.15860626077564" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="21" UNITS="" WEIGHT="100.0" Z="0.45519027352506813">
<NAME>Morning stiffness (min) 6 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="17.190225170413257" CI_START="-27.590225170413248" EFFECT_SIZE="-5.199999999999996" ESTIMABLE="YES" MEAN_1="40.6" MEAN_2="45.8" ORDER="67" SD_1="34.2" SD_2="40.3" SE="11.423794185517943" STUDY_ID="STD-Sarzi_x002d_Puttini-2000" TOTAL_1="22" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.74016940387635" CI_START="-6.940169403876368" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.3999999999999915" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2008-08-15 10:50:49 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.742152621332011" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="21" UNITS="" WEIGHT="100.0" Z="0.32900405800878835">
<NAME>Body weight (kg) 6 months follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.74016940387635" CI_START="-6.940169403876368" EFFECT_SIZE="1.3999999999999915" ESTIMABLE="YES" MEAN_1="69.1" MEAN_2="67.7" ORDER="68" SD_1="14.5" SD_2="13.4" SE="4.255266662888987" STUDY_ID="STD-Sarzi_x002d_Puttini-2000" TOTAL_1="22" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2008-08-04 11:53:11 -0400" MODIFIED_BY="Jenny Bellorini" NO="7">
<NAME>Possible adverse effects - any diet manipulation vs ordinary diet</NAME>
<DICH_OUTCOME CHI2="6.748738906453645" CI_END="0.177615405674741" CI_START="0.020729583044781022" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RD" EFFECT_SIZE="0.09917249435976101" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="36" I2="25.912084178888165" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="-0.7505193678965888" LOG_CI_START="-1.683409433225576" LOG_EFFECT_SIZE="-1.0036087633718465" METHOD="MH" MODIFIED="2008-08-04 11:53:01 -0400" MODIFIED_BY="Jenny Bellorini" NO="1" P_CHI2="0.2400077909706253" P_Q="0.0" P_Z="0.013215427354993738" Q="0.0" RANDOM="NO" SCALE="0.3940004156866092" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="193" TOTAL_2="181" WEIGHT="99.99999999999999" Z="2.4779105459464783">
<NAME>Total drop-outs</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.13577817094125758" CI_START="-0.12074057695629517" EFFECT_SIZE="0.007518796992481203" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="69" O_E="0.0" SE="0.06543965856539709" STUDY_ID="STD-Hafstr_x00f6_m-2001" TOTAL_1="38" TOTAL_2="28" VAR="0.004282348913155748" WEIGHT="17.318768355526814"/>
<DICH_DATA CI_END="0.31337494899955975" CI_START="-0.010344645969256744" EFFECT_SIZE="0.1515151515151515" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="70" O_E="0.0" SE="0.08258304681164433" STUDY_ID="STD-Hansen-1996" TOTAL_1="54" TOTAL_2="55" VAR="0.0068199596206942395" WEIGHT="29.271788758453184"/>
<DICH_DATA CI_END="0.5853362842600383" CI_START="0.06321444037764296" EFFECT_SIZE="0.32427536231884063" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="71" O_E="0.0" SE="0.1331967954515557" STUDY_ID="STD-Kavanagh-1995" TOTAL_1="23" TOTAL_2="24" VAR="0.01774138631856357" WEIGHT="12.617128633989621"/>
<DICH_DATA CI_END="0.28232188207788245" CI_START="-0.23388883364483404" EFFECT_SIZE="0.024216524216524205" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="72" O_E="0.0" SE="0.1316888268852185" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="27" TOTAL_2="26" VAR="0.017341947126405043" WEIGHT="14.229202288414463"/>
<DICH_DATA CI_END="0.23171978517272754" CI_START="-0.1494687029216453" EFFECT_SIZE="0.04112554112554112" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="73" O_E="0.0" SE="0.09724374812525612" STUDY_ID="STD-Nenonen-1998" TOTAL_1="22" TOTAL_2="21" VAR="0.009456346549448252" WEIGHT="11.542312569870687"/>
<DICH_DATA CI_END="0.17784617975327977" CI_START="-0.11909777617728999" EFFECT_SIZE="0.029374201787994894" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="74" O_E="0.0" SE="0.07575240113410904" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="29" TOTAL_2="27" VAR="0.005738426277582965" WEIGHT="15.020799393745213"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.227828178004184" CI_END="0.13588876480664186" CI_START="-0.03125783536071624" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RD" EFFECT_SIZE="0.052315464722962814" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="-0.8668164489642316" LOG_CI_START="NaN" LOG_EFFECT_SIZE="-1.2813699124506834" METHOD="MH" MODIFIED="2008-08-04 11:53:11 -0400" MODIFIED_BY="Jenny Bellorini" NO="2" P_CHI2="0.5204481270823553" P_Q="0.0" P_Z="0.21985865076177336" Q="0.0" RANDOM="NO" SCALE="0.2527804319112084" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="109" TOTAL_2="99" WEIGHT="100.00000000000001" Z="1.2269041259447295">
<NAME>Treatment-related drop-outs</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.3306174698773928" CI_START="-0.06395080321072619" EFFECT_SIZE="0.13333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="75" O_E="0.0" SE="0.10065702130254005" STUDY_ID="STD-Holst_x002d_Jensen--1998" TOTAL_1="15" TOTAL_2="15" VAR="0.0101318359375" WEIGHT="14.52771612971529"/>
<DICH_DATA CI_END="0.1407590893951373" CI_START="-0.30885025748630535" EFFECT_SIZE="-0.08404558404558404" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="76" O_E="0.0" SE="0.11469836956900836" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="27" TOTAL_2="26" VAR="0.013155715981788822" WEIGHT="25.65649490078021"/>
<DICH_DATA CI_END="0.29582106674124165" CI_START="-0.023093794013968966" EFFECT_SIZE="0.13636363636363635" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="77" O_E="0.0" SE="0.08135732678528033" STUDY_ID="STD-Nenonen-1998" TOTAL_1="22" TOTAL_2="21" VAR="0.006619014621646894" WEIGHT="20.811797990475856"/>
<DICH_DATA CI_END="0.24506878269887541" CI_START="-0.12006878269887541" EFFECT_SIZE="0.0625" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="78" O_E="0.0" SE="0.09314904974731918" STUDY_ID="STD-Sk_x00f6_ldstam-1979" TOTAL_1="16" TOTAL_2="10" VAR="0.008676745468828542" WEIGHT="11.92017733720229"/>
<DICH_DATA CI_END="0.17936322526787699" CI_START="-0.04143219078511837" EFFECT_SIZE="0.06896551724137931" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="79" O_E="0.0" SE="0.05632639624875799" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="29" TOTAL_2="27" VAR="0.003172662914372098" WEIGHT="27.083813641826364"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.12083920834382225" CI_END="-1.670890331438786" CI_START="-4.7863286404682" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.228609485953493" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.03" MODIFIED="2008-05-13 09:44:23 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9982466176536091" P_Q="1.0" P_Z="4.858679020468387E-5" Q="0.0" RANDOM="NO" SCALE="11.874283346710302" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="96" UNITS="" WEIGHT="100.00000000000001" Z="4.062322976688723">
<NAME>Body weight (kg)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.8060067690735" CI_START="-13.8060067690735" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="0.0" ORDER="80" SD_1="14.7" SD_2="19.2" SE="5.003156612275546" STUDY_ID="STD-Kavanagh-1995" TOTAL_1="24" TOTAL_2="23" WEIGHT="2.5234455788190617"/>
<CONT_DATA CI_END="5.542138276019143" CI_START="-14.742138276019142" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-4.6" MEAN_2="0.0" ORDER="81" SD_1="16.1" SD_2="14.0" SE="5.1746554304155765" STUDY_ID="STD-Kjeldsen_x002d_Kragh-1991" TOTAL_1="17" TOTAL_2="17" WEIGHT="2.3589528791712775"/>
<CONT_DATA CI_END="9.357345003165356" CI_START="-14.557345003165356" EFFECT_SIZE="-2.6" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-1.9" ORDER="82" SD_1="20.8" SD_2="19.2" SE="6.100798329705733" STUDY_ID="STD-Sarzi_x002d_Puttini-2000" TOTAL_1="22" TOTAL_2="21" WEIGHT="1.6971053415928428"/>
<CONT_DATA CI_END="-1.5672194202643999" CI_START="-4.8327805797356005" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-2.6" MEAN_2="0.6" ORDER="83" SD_1="2.1" SD_2="2.0" SE="0.8330666239863411" STUDY_ID="STD-Sk_x00f6_ldstam-1979" TOTAL_1="15" TOTAL_2="10" WEIGHT="91.01703171109999"/>
<CONT_DATA CI_END="7.447784345831028" CI_START="-12.647784345831028" EFFECT_SIZE="-2.6" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-0.4" ORDER="84" SD_1="19.1" SD_2="17.5" SE="5.126514785519871" STUDY_ID="STD-Sk_x00f6_ldstam-2003" TOTAL_1="26" TOTAL_2="25" WEIGHT="2.403464489316837"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2008-08-15 10:51:44 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Allergen-free diet vs allergen-restricted diet</NAME>
<CONT_OUTCOME CHI2="2.715272263361224E-33" CI_END="20.603659195473497" CI_START="-12.803659195473493" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.9000000000000017" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2008-08-15 10:51:27 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.6472284410564391" Q="0.0" RANDOM="NO" SCALE="20.99491861912011" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="0.4576158702865307">
<NAME>Change in morning stiffness (min) 4 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="20.603659195473497" CI_START="-12.803659195473493" EFFECT_SIZE="3.900000000000002" ESTIMABLE="YES" MEAN_1="-23.4" MEAN_2="-27.3" ORDER="85" SD_1="39.1" SD_2="36.0" SE="8.522431701413815" STUDY_ID="STD-van-de-Laar-1992" TOTAL_1="38" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.8884537001701918" CI_START="0.3115462998298084" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.1" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.02" MODIFIED="2008-08-15 10:51:44 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.006249104496616181" Q="0.0" RANDOM="NO" SCALE="2.008858689777396" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="40" UNITS="" WEIGHT="100.0" Z="2.734415961937505">
<NAME>Change in body weight (kg) 4 weeks follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.8884537001701918" CI_START="0.3115462998298084" EFFECT_SIZE="1.1" ESTIMABLE="YES" MEAN_1="-2.1" MEAN_2="-3.2" ORDER="86" SD_1="1.4" SD_2="2.1" SE="0.4022796879888681" STUDY_ID="STD-van-de-Laar-1992" TOTAL_1="38" TOTAL_2="40" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-07-22 09:29:42 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-07-22 09:29:42 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-22 09:28:46 -0400" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-22 09:29:42 -0400" MODIFIED_BY="[Empty name]">
<P>1. Exp arthritis, rheumatoid/<BR/>2. (felty$ adj2 syndrome).tw.<BR/>3. (caplan$ adj2 syndrome).tw.<BR/>4. rheumatoid nodule.tw.<BR/>5. (Sjogren$ adj2 syndrome).tw.<BR/>6. (sicca adj2 syndrome).tw.<BR/>7. still$ disease.tw.<BR/>8. Bechterew$ disease.tw.<BR/>9. (arthritis adj2 rheumat$).tw.<BR/>10. or/1-9<BR/>11. exp Diet/<BR/>12. exp Diet Therapy/<BR/>13. exp Diet, Vegetarian/<BR/>14. exp Diet, Mediterranean/<BR/>15. exp Nutrition Therapy/<BR/>16. diet$.tw.<BR/>17. (lacto-vegetarian$ or lacto vegetarian$ or vegetarian$ or non-vegetarian or (non adj vegetarian$)).tw.<BR/>18. vegan$.tw.<BR/>19. (Cretan or Mediterranean).tw.<BR/>20. exp Fasting/<BR/>21. fast$.tw.<BR/>22. or/11-21<BR/>23. 10 and 22<BR/>24. randomized controlled trial.pt.<BR/>25. controlled clinical trial.pt.<BR/>26. randomized controlled trials.sh.<BR/>27. random allocation.sh.<BR/>28. double blind method.sh.<BR/>29. single-blind method.sh.<BR/>30. or/24-29<BR/>31. (animal$ not human).sh.<BR/>32. 30 not 31<BR/>33. clinical trial.pt.<BR/>34. exp clinical trials/<BR/>35. (clin$ adj25 trial$).ti,ab.<BR/>36. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.<BR/>37. placebo$.sh.<BR/>38. placebo$.ti,ab.<BR/>39. random$.ti,ab.<BR/>40. research design.sh.<BR/>41. or/33-40<BR/>42. 41 not 31<BR/>43. 42 not 32<BR/>44. comparative study.sh.<BR/>45. exp evaluation studies/<BR/>46. follow up studies.sh.<BR/>47. prospective studies.sh.<BR/>48. (control$ or prospectiv$ or volunteer$).ti,ab.<BR/>49. or/44-48<BR/>50. 49 not 31<BR/>51. 50 not (32 or 43)<BR/>52. 23 and 51</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>